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Abstract 
Arthritis is a pathological condition whereby a persistent inflammatory response 
leads to breakdown of articular cartilage in synovial joints. Cartilage is a 
specialised avascular tissue containing chondrocytes embedded in an extracellular 
matrix. The cartilage matrix is composed of collagen to provide strength with 
aggregated proteoglycan to facillitate hydration. Cartilage has been reported to 
loose proteoglycans with concordant loss of integrity observed in arthritic disease 
pathology. Proteoglycans Joss from cartilage has also been reported in in vitro 
models. Application of interleukin-1 (lL-113) to cartilage in vitro has been 
demonstrated to increase Joss of proteoglycans and modulate production of 
inflammatory mediators such as Nitric Oxide (NO) and Prostaglandin-E2 (PGE2). 
NO and PGE2 have also been associated with cartilage breakdown. Other 
cytokines such as colony stimulating factors (CSFs) may regulate cartilage 
function . The aim of this study was to select a cartilage explant system and 
compare the effects of interleukin-1 (lL-1) with those of colony stimulating 
factors (CSFs) by measuring the production of NO and PGE2 and release of 
proteoglycans. 
It was found that IL-113 increased PGE2 and NO production, but not Joss of 
proteoglycans from rat cartilage explants. Granulocyte-CSF (G-CSF) and lL-3 
increased production of NO and PGE2, respectively. When combined, IL-113 I 
Granulocyte-Macrophage (GM-CSF) increased production of PGE2 and G-CSF I 
IL-113 produced increased proteoglycan Joss from explants. 
16 
The model was then modified by integrating Swiss 3T3 Fibroblasts monolayers 
with explants. Fibroblasts were initially screened to determine their separate 
response to these cytokines. Fibroblasts did not release proteoglycans into the 
culture media, but produced elevated concentrations ofNO and PGE2 in response 
to IL-l~ · 
Fibroblast-cartilage co-cultures treated with IL-l~ produced increased NO, PGE2 
and proteoglycan release. G-CSF, GM-CSF and IL-3 caused increased levels of 
PGE2 in co-cultures, however, lL-1 ~ was required to generate significant 
proteoglycan loss from cartilage explants. Finally, extra-cellular signal related 
protein kinases I and 2 (ERK 1&2) and p38 intracellular signalling pathways were 
shown to be involved in lL-1 ~ mediated production of NO fibroblasts and 
explants. 
These studies show that IL-l~ has increased potential to mediate cartilage 
breakdown when interacting with other cytokines, such as G-CSF, and other cell 
types, such as Swiss 3T3 fibroblasts. IL- l f3 has defined intracellular signalling 
pathways that may produce a range of responses in cartilage explants and 
fibroblasts. These studies may relate to production of inflammatory processes and 
loss of cartilage integrity and function in pathological conditions. 
17 
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Chapterl: 
Introduction 
30 
1.1.0: Inflammation and arthritis 
Inflammation is a normal physiological response that may be induced by tissue 
damage or foreign tissue recognition by the immune system. Inflammation is 
associated with diseases such as rheumatoid (RA) and osteoarthritis (OA). The 
purpose of the inflammatory response is to repair tissue damage, prevent further 
infection and remove any foreign material from an affected area. However, the 
inflammatory reponse is peristent within arthritic disease pathology and leads to 
connective tissue damage. The mechanisms involved in the progression of RA are 
distinct from those in OA. RA is a disease that principally involves damage to 
joints but also produces extra-articular manifestations. RA affects 0.03% to 1.5% 
of the population, with females affected 2 to 3 times more often than males. Life-
span is decreased on average by 7.5 years for men and 3.5 years for women. 
Osteoarthritis (OA) is the most common joint disease and is strongly related to 
age. OA is a condition of synovial joints characterised by focal cartilage Joss and 
an accompanying reparative bone response. Typical radiographic features are joint 
space narrowing and the presence of osteophytes and sclerosis. OA is an 
uncommon disease within individuals under 45 years, however, at least half the 
population have radiographic evidence of OA at 65 years. There are a number of 
similarities in the pathology of both RA and OA. A number of inflammatory 
mediators have been identified in both RA and OA that are associated with the 
destruction of articular cartilage and bone. It is these factors that may contribute to 
the changes from normal joint physiology to arthritic disease pathology. 
31 
1.1.1: Normal joint physiology 
A normal joint is designed to carry out a wide range of movements. Synovial 
joints contain cartilage that is smooth in appearance and has shock absorbing 
properties (see Fig: 1.11.) required for normal movement. The joint is lined by 
membrane called synovium that consists of cells called synoviocytes. 
Synoviocytes have been categorised by Freemont, ( 1996) into two cell types; 
macrophage-derived phagocytes and mesenchymal connective tissue lineage 
derived cells that produce synovial fluid factors that aid joint lubrication. 
However, the nornal synovial joint physiology may undergo a series of changes 
that lead to disease pathology associated with arthritis disease pathologies. 
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Fig: 1.1.1: Diagram of Normal joint (A) and photograph of normal femoral 
head (B). 
ball offrnwr 
Fig: 1.1.1: A: Diagram shows the femoral head inter-locking into the pelvis to 
form a normal femoral joint (Picture adapted from American Academy of 
Orthopaedic Surgeons web page, see Appendix fV). B: Photograph shows the 
smooth appearance of cartilage coating the femoral head from a joint with normal 
physiology. 
1.1.2: Disease joint pathology. 
The joint space is infiltrated by a range of inflammatory cells such as T cells, 
macrophages and plasma cells in RA disease pathology. Cellular accumulation is 
accompanied by release of inflammatory mediators such as cytokines, chemokines 
reactive oxidative species (ROS), metalloproteinases and prostaglandins that 
promote the inflammatory process (Odeh, 1997). An increase in the number of 
cells comprising the synovium is also apparent in the pathological joint (Feldmann 
et al. , 1996). Intra-articular foreign material accumulates in synovium and 
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synovial fluid , consisting of breakdown products from articular cartilage, bone and 
the synovium (Freemont, 1996). 
The appearance of cartilage is notably different in pathological conditions 
compared to that observed in the normal physiological joint. Cartilage surface is 
fibrillated, unevenly distributed on the joint surface and unable to confer shock 
absorbing properties required for normal movement, (see Fig: 1.1.2). 
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Fig: 1.1.2: Diagram of pathological joint (A) and photograph of a 
pathological femoral head (B). 
Fig: 1.1.2: A: Diagram shows the femoral head associated with the pelvis to form 
a pathological joint (picture adapted from American Academy of Orthopaedic 
Surgeons web page, see Appendix IV). B: Picture shows the unsmooth appearance 
and uneven distribution of cartilage coating the femoral head from an OA 
pathological joint. 
The damage to cartilage structure in arthritic disease is due to the activity of 
metabolites and inflammatory mediators that change the structural integrity of the 
cartilage matrix (Jeffrey, 1994). To explore this suggestion further, it is necessary 
to review the ultra-structure of cartilage and interactions with metabolites and 
inflammatory mediators that may promote the catabolic process. 
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1.1.3: Cartilage 
Cartilage is a form of avascular connective tissue that contains chondrocytes 
within a specialised extracellular matrix. Cartilage is composed of 90-95% type II 
collagen with small amounts oftypes V, VI, IX, X and XI collagen also present in 
the cartilage matrix (Silver and Glasgold, 1995). Collagen fibrils form a 
cartilaginous framework that provides tensile strength. The collagen matrix 
consists of water (60-80% wet weight), collagen (1 0-20% wet weight), 
proteoglycans (1 0-15% wet weight) and other components such as adhesive 
molecules and lipids (Studer et a!. , 1996). Load bearing capacity of articular 
cartilage is made possible through regional changes in water concentration which 
allow deformation of the cartilage surface in response to mechanical stress 
(Jeffrey, 1994) . Proteoglycans facilitate hydration of cartilage by producing an 
osmotic potential that maintains the water content (Bottomley eta!. , 1997). 
1.1.4: Proteoglycans in cartilage 
The most abundant proteoglycan in articular cartilage is named aggrecan 
(Billington et a!., 1998) representing up to 10% of the dry weight. Aggrecan is a 
glycoprotein containing aggregated glycosaminoglycan (GAG) chains (Bolton et 
a!., 1999). Many individual monomers of aggrecan bind to hyaluronic acid to form 
an aggregate. The aggregate monomer is termed aggrecan (see Fig 1.1.4). 
Fig. 1.1.4: Aggrecan structure 
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Fig. 1.1.4: Diagram shows structure of aggrecan. Aggrecan is bound non-
covalently to hyaluronan (HA) and a stabilised link protein. Aggrecan is 
composed of G I, G2 individual sulphated GAGs and a G3 domain associated with 
a protein core. The sulphated GAGs produce an osmotic potential that maintains 
hydration of the cartilage matrix and therefore increases its ability to withstand 
compressive forces (diagram produced using Microsoft Powerpoint 97). 
These aggregates are comprised of up to I 00 monomers attached to a single chain 
of hyaluronic acid (HA). An aggrecan monomer consists of a protein backbone of 
210-250 kDa to which is attached both chondroitin sulphate and keratan sulphate 
chains (Hering et a/. 1997). The chains are attached to the central portion of the 
core protein, chondroitin sulphate chains (I 00- 150 per monomer), being located in 
the C terminus and keratan sulphate is preferentially located towards the N 
terminus (Caterson et. a!., 2000). Individual aggrecan monomers, up to I 00, 
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interact with hyaluronic acid to form a high molecular weight aggregate. This 
interaction involves a globular domain at the N-terminus, termed G 1 or the 
hyaluronic acid binding region (HABR). The interaction is stabilised by a short 
protein called link protein which interacts with both the HA and G 1. There is 
considerable sequence homology between link protein and G 1, and with G2, a 
further globular domain close to G 1 on the aggrecan core protein, termed G2. 
Although it is not involved in the binding with either link protein or hyaluronic 
acid, it shares considerable sequence homology with G 1. A function for G2 has 
not been identified, (Sztrolovics et al., 1997). 
A third globular domain, G3, is located at the C-terminus, and has three structural 
domains: an EGF repeat, a lectin-like sequence, and a region homologous to the 
complement regulatory protein (CRP) motif. The lectin-like domain appears to be 
present in all forms of the molecule, while the EGF and CRP like domains are 
only present in an alternatively spliced variant. The roles of the various 
components ofG3 have not been determined (Iozzo, 1998). 
While aggrecan is found in cartilage, there are considerable similarities emerging 
between it and several other large proteoglycans. There are homologies with 
versican and the hyaluronate receptor CD44. Versican has a C-terminallectin like 
domain and EGF-like repeats along with a central GAG binding domain, which 
unlike aggrecan is glycosylated exclusively with chondroitin sulphate (lozzo, 
1998). 
38 
The primary role of aggrecan is to induce osmotic swelling and maintain hydration 
in the cartilage extracellular matrix. In this way aggrecan plays a crucial role in the 
normal function of articular cartilage. The extracellular matrix of articular 
cartilage is comprised of fibril forming collagens, aggrecan and many other 
important molecules. The presence of very large numbers of chondroitin sulphate 
chains within the aggrecan molecule generates an osmotic swelling pressure. It is 
this hydration that is essential to the load bearing function of articular cartilage. 
Aggrecan catabolism involves release of the chondroitin sulphate into synovial 
fluid, a process that may be upregulated during inflammatory processes in and 
around the cartilage matrix (Billington eta/., 1998). 
Subunits of glycosaminoglycans (GAGs) compose the structure of the aggrecan 
molecule. GAGs within cartilage include chondroitin-4-sulfate, chondroitin-6-
sulfate and keratan sulfate. These molecules are bound to a protein core by sugar 
bonds to form an aggrecan molecule. Aggrecan molecules are further stabilised by 
link proteins which bind them to hyaluronan to form a proteoglycan aggregate. 
Loss of proteoglycans from the cartilage matrix cause reduced hydration and 
therefore reduce the load bearing capacity. Chondrocytes embedded in the 
cartilage matrix are responsible for the turnover of these proteoglycan moieties. 
Chondrocytes both synthesise and facilitate the removal of proteoglycans in the 
cartilage matrix. Articular cartilage has been shown to be a heterogenous tissue 
that has varying composition with respect to both proteoglycans and chondrocytes 
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when moving from through the articular surface toward the epiphyseal growth 
plate (Bayliss eta/., 1983). 
1.1.5: Zonal variations in cartilage 
Articular cartilage varies in ultrastructure and composition with distance from the 
articular surface (Siczkowski and Watt, 1990). It has been demonstrated that 
amounts of both chondroitin sulphate and keratan sulphate vary in different 
regions of human articular cartilage (Bayliss et a/., 1983). This variation in 
cartilage structure can be divided into four zones: superficial, intermediate, deep 
and calcified as described by Silver and Glasgold, (1995). 
1.1.5.1: Superficial Zone 
The upper zone of cartilage is the uppermost surface of extracellular matrix that is 
exposed to the synovial joint space. It is composed of abundant tangentially 
oriented collagen fibres with associated proteoglycans and concordant hydration. 
Immunostaining has shown that proteoglycans and link protein are present, 
however, cationic stains were more intense in deeper regions of cartilage (Poole et 
a/., 1989) Chondrocytes maintain a discoid flattened morphology, reside parallel 
to the surface and have low metabolic activity. Chondrocytes derived from the 
upper zone were shown to attach and spread more slowly in vitro than 
chondrocytes deeper within the cartilage structure (Siczkowski and Watt, 1990). 
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1.1.5.2: Intermediate Zone 
The intermediate zone is the layer below the superficial sliding zone. This is 
constructed of thicker collagen fibrils with chondrocytes arranged singly or in 
pairs. Cationic staining suggests that proteoglycan levels are elevated in this 
region compared to the upper zone (Poole eta/., 1987). 
1.1.5.3: Deep Zone 
The deep zone contains larger collagen fibrils with vertical (radial) orientation 
compared to the other zones. Chondrocytes in this region are aligned 
perpendicular to the joint surface, (Poole eta/. 1984). 
1.1.5.4:Calcified Zone 
The calcified zone is defined by a transition between unmineralised and calcified 
cartilage. Matrix vesicles appear to bud off from the ends of chondrocyte 
cytoplasmic processes and may play a role in the mineralisation process in this 
region, (Silver and Glasgold, I 995). Activity of chondrocytes in cartilage matrix 
may be the key factor in regulation of cartilage functional capacity (Siczkowski 
and Watt, I 990). 
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1.1.6: Cbondrocytes 
Chondrocytes in cartilage are essential to the functional stability of the matrix. 
Chondrogenesis, the formation of articular cartilage and growth, is initiated by 
chondroprogenitor cells that aggregate and synthesise ECM (Siczkowski and 
Watt, 1990). These cells eventually become separated and surrounded by 
extracellular matrix. During the initial stages of development the cell density is 
high, and large volumes of ECM are synthesized. As the articular cartilage matrix 
structure is formed the cells proliferation and ECM synthesis is maintained to 
sustain a continual turnover of matrix without a change in volume (Buschmann et 
al. , 1992). At this stage chondroprogenitor cells have differentiated into 
chondrocytes (Mankin, 1974) (Fig. 1.1.6). 
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Fig. 1.1.6: Chondrocytes in the cartilage matrix 
Fig. 1.1.6: Image of H&E stained chondrocytes within the cartilage matrix. A: 
Chondrocyte in the cartilage matrix. Chondrocytes are surrounded by a halo of 
light pink staining proteoglycans. Picture adapted from Microanatomy Web Atlas, 
(Appendix TV). 
The matrix is a dynamic structure that is constantly subjected to both mechanical 
abrasion due to physical forces and chemical breakdown by release of endogenous 
proteases. Chondrocytes synthesize collagen and proteoglycans to maintain the 
integrity of the extracellular matrix. It has been suggested that mechanical forces 
on cartilage may play an important role in the anabolic activity of chondrocytes in 
the matrix (Hammrick, 1999). Chondrocytes have also been shown to induce the 
removal of proteoglycans and collagens from the matrix. This observation has 
been noted when articular cartilage is treated with inflammatory mediators such as 
IL-113 (Sandy et al., 1995) and TNF-a. (Homandberg et al. , 1996). Chondrocytes 
also express CD44 as a primary receptor for hyaluronan. Hyaluronan is 
responsible for the retention and orientation of proteoglycans in the cartilage 
matrix (Aguiar et al., 1999). Levels of hyaluronan in the matrix and its 
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interactions with proteoglycans may be directly regulated by chondrocytes. Indeed, 
a study by Dsouza et a/. (2000) revealed that both aggrecan and hyaluronan 
metabolism in chondrocytes are differentially regulated by IL-l and that 
hyaluronan concentrations in the ECM may regulate the stability of proteoglycan 
aggregates. 
Studies have shown that chondrocyte membranes have an aggrecanase activity 
(Billington et a/. , 1998) that catalyses the breakdown of aggrecan molecules and 
that chondrocytes produce soluble proteases termed metalloproteinases (MMPs) 
that facilitate collagen (Wertheimer et a/. , 1995) and proteoglycan (Bottomley et 
a/. , 1 997) loss from cartilage. Chondrocytes also produce other mediators that may 
facilitate GAG loss from articular cartilage such as nitric oxide (Evans and 
Stefanovicic, 1996) and prostaglandin-E2 (Prete et a/., 1997). It has also been 
suggested that NO facilitates increased MMP activity in cartilage (Murrell et a/., 
1995). 
1.1.7: Nitric Oxide and cartilage function 
Nitric oxide is a short lived, gaseous free radical, synthesized in the process of 
enzymic deamination of L-arginine to L-citrulline by NO synthases (NOS) 
(Nathan, 1994). There are three isoforms of NOS. Two forms are constitutive 
forms, eNOS and nNOS, the third type is an inducible isoform named iNOS. 
(Stuehr, 1997). NOS enzymes are dimeric in structure, calmodulin independent 
(iNOS) or possess binding domains (eNOS and nNOS), bear both FAD and FMN 
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and require tetrahydrobiopterin as a cofactor to produce NO (Nathan and Xie, 
1994). 
The in vivo synthesis of NO and its role in animal models of arthritis and human 
inflammatory joint disease may facilitate the development and maintenance of 
inflammatory conditions (Stichtenoth and Frolich, 1998). Articular chondrocytes 
have been shown to produce NO in response to cytokines and lipopolysaccharide 
(Stadlereta/., 1991). 
In a study by Stichtenoth eta/, (1994) its was demonstrated that adjuvant induced 
arthritis in rats caused an increase in urinary nitrate output compared to normal 
controls. Treatment of rats with L-nitro-arginine-methyl-ester (L-NAME), a non-
specific inhibitor of iNOS reduced urinary nitrate excretion in adjuvant arthritic 
rats and reduced disease severity. A study by Farrell eta/. (1992) showed that in 
human patients suffering from rheumatoid and osteoarthritis, serum and synovial 
fluid concentrations of nitrite were elevated compared to controls. Further 
evidence for involvement of NO in inflammatory diseases was produced by Kaur 
and Halliwell (1994) who showed that nitrotyrosine concentrations were elevated 
in serum and synovial fluid of patients with RA. Nitrotyrosine may be formed as a 
reaction product of peroxynitrite with tyrosine residues. Peroxynitrite is a 
shortlived highly reactive intermediate generated by NO degradation to nitrite 
(Vand der Vliet eta/., 1994). 
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There is evidence that links lipid peroxidation by reactive oxidative species (ROS) 
to cartilage matrix protein degeneration (Tiku et al., 2000). In this study, ROS 
were generated and combined with anti-oxidants in the presence of chondrocytes 
and matrix proteins. It was found that the release of chondrocyte matrix 
components mediated by ROS was suppressed by the presence of vitamin E. The 
authors quantified peroxidation in this study by measuring cis-parinaric acid and 
concluded that ROS may regulate the pathogenesis of cartilage degeneration. 
There is evidence that nitric oxide may have a direct role in facilitating the release 
of proteoglycans from the cartilage matrix. A study by Hassan et al., (1998) 
showed that an artificial donor of nitric oxide, S-nitroso-N-acetyl-penicillamine 
(SNAP), caused increased degradation of GAGs in vitro. The report suggested that 
nitric oxide may facilitate degradation of GAGs directly and, or, peroxynitrite may 
also contribute to GAG degradation. 
NO may also activate metalloproteinase (MMP) enzymes in articular cartilage 
(Murrell et al. 1995). The conclusions of this study suggest that MMP activity was 
reduced using L-NAME. The activity of MMPs was restored by addition of 
exogenous NO. 
Many studies of NO in inflammatory models also consider the inter-relationship 
between NO and PGE2 production and activity. These include studies of human 
chondrocytes (Blanco and Lotz, 1995), human osteoarthritic cartilage (Amin et al., 
1997) and rheumatoid synovial cells (Honda et al., 2000). 
46 
1.1.8: Prostaglandin-E2 and cartilage function 
Prostaglandins are produced from polyunsaturated fatty acids by a series of 
reactions involving oxygenation, cyclization and the generation of five chiral 
centers from an achiral substrate (Marnett et al. , 1999). The first two stages in the 
prostaglandin biosynthetic pathway are catalysed by the enzymes cyclooxygenase 
(COX) I and 2 from the substrate arachidonic acid (AA). AA is transformed into 
primary prostanoids by differential enzymes and POE isomerase is responsible for 
the generation of PGE2 (Vane et al. , 1998). 
COX I is a constitutive isoform, whereas COX 2 is an inducible isoform (Vane et 
al. , 1998). Both enzymes have a molecular weight of 71 KDa and possess 63 % 
sequence homology (Vane et al. , 1998). Willoughby et al. , (2000) have speculated 
the existence of a COX-3 enzyme, however, this has not been substantiated. 
Many NSAIDs used to reduce symptoms of RA have been shown to inhibit the 
activity of COX enzymes (Emery, 1999). PGE2 is a product of these enzymes that 
has been studied in several models relating to inflammatory joint disease. 
A study by Blanco and Lotz (1995) revealed that chondrocytes producing PGE2 in 
response to treatment with IL-l f3 showed an increased level of cell proliferation. 
This effect was reduced by addition of indomethacin, a non-specific inhibitor of 
COX activity. This study also showed that LL-1 f3 induced NO production, which 
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in turn, induced PGE2 production in the chondrocytes. PGE2 production induced 
by IL-1f3 was inhibited by addition of NG-monomethyl arginine (L-NMMA), a 
NOS inhibitor. Thus, a link was established between PGE2 and NO production 
with regard to chondrocyte monolayers in vitro. 
The association between NO and PGE2 was reviewed by Sautebin et a/., (1998). 
Indeed, similarities have been demonstrated in the NOS and COX pathways. Both 
enzymes have constitutive and inducible isoforms, are inhibited by glucocorticoids 
and induced by LPS and inflammatory cytokines. 
Amin et al. (1997) showed that there was an apparent link between PGE2 and NO 
in osteoarthritic cartilage. This study suggested that inhibition of NO by L-NMA, 
caused a reduced levels of PGE2 in tissue culture supernatants. The authors 
concluded that NO may inhibit the production of endogenous PGE2 in 
osteoarthritic cartilage explants. The studies by Blanco and Lotz ( 1995) and Am in 
et al. ( 1997) revealed relationships between PGE2 and NO in chondrocytes and 
cartilage explants, respectively. The activity of COX-2 in chondrocytes via 
IL-l f3 induction has been linked to an intracellular signalling pathway involving 
C/CAAT-enhancer binding protein (Thomas et al., 2000). 
Induction of COX expression was also examined in rheumatoid synovial cells 
(Honda et al. , 2000). It was suggested that SNAP, an exogenous donor of NO, 
could induce expression of COX-2 in these cells. It was concluded by the authors 
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that increased COX-2 expression may exacerbate inflammatory responses through 
production of mediators such as prostaglandins. 
The effect of prostaglandin-E2 on cartilage in vivo is uncertain. Indeed, it may 
have a catabolic effect by increasing expression of other inflammatory mediators 
in chondrocytes and cells surrounding the inflamed joint and increasing 
angiogenic potential. Conversely, it may have beneficial effects by increasing 
aggrecan synthesis (Armin et al. , 1997). However, it is apparent that IL-113 and 
TNF-a are pivotal in the induction of both PGE2 (Blanco and Lotz, 1995), 
(Berenbaum et al. , 1996) (Armin et al. 1997) and NO (Stefanovic-Racic et a/. 
1997), (Armin et al. 1997), (Bird et. al. 1997) , (Badger et a/. 1998) in articular 
cartilage. 
1.1.9: Cytokines and cartilage function in in vitro models 
Analysis of cytokine mRNA and protein in RA tissues has revealed that many 
cytokines such as IL-113, TNFa, fL-6, GM-CSF are detected in elevated 
concentrations. Cytokines are local protein mediators involved in processes such 
as cell growth and activation, inflammation, immunity and differentiation. The 
destruction of cartilage observed in arthritic diseases is considered to be a 
consequence of production of MMPs in response to cytokines such as IL-113 and 
TNFa (Feldmann et a/., 1996). It has been demonstrated that inhibition of TNFa 
using anti-TNFa antibodies and inhibition of IL-113 production reduces joint 
49 
damage in murine in vivo models of arthritic disease. The effects of these 
cytokines were reviewed within in vitro models using cartilage chondrocytes and 
explants (sections 1.1.9.1, 1.1.9.2 and 1.1.9.3). 
1.1.9.1: Effects oflnterleukin-1 (IL-l) on chondrocytes and cartilage explants 
IL-l is a multi-functional cytokine that affects nearly every cell type and often in 
concert with other cytokines and mediators (Dinarello, 1996). ll..,-1 is produced in 
two 17kD variants, ll..,-1 a and IL-l [3, and is commonly associated with the 
inflammatory response. It has been shown that ll..,-1 f3 may increase production of 
inflammatory mediators such as NO, PGE2 and MMPs that may regulate cartilage 
breakdown. 
ll..,-1 f3 has been used in many studies to determine its effects on cartilage in vitro. 
Previous studies have demonstrated that cartilage derived from different species 
and locations react differently to cytokines within an in vitro environment. 
Previous studies using bovine cartilage explants (Spirito et a/., 1995; Wertheimer 
et a/., 1995; Hanglow et a/., 1995; Bonassar et a/. , 1997; Steinmeyer et a/. , 1997; 
Badger et a/., 1998 ) and chondrocytes (Badger et a/., 1998; Dsouza et a/., 2000) 
have shown that ll..,-1 f3 has multiple biological actions. Spirito et al., ( 1995) 
showed that IL-l a caused 90 % release of proteoglycans from bovine nasal 
cartilage explants during the intial 7 days of culture followed by loss of collagen 
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by day 21 of culture. The effect of lL-1 P in this study was inhibited by MMP 
inhibitors CGS 20723 and Ro 31-9790. Wertheimer et a/., (1995) demonstrated 
that the MMP, stromelysin, was expressed in bovine occipital cartilage following 
treatment with lL-1 p. Bonassar at a/., ( 1997) demonstrated that lL-1 p produced 
>90% GAG loss in bovine cartilage isolated from the femoropatellar groove; this 
effect was inhibited by tissue inhibitor of metalloproteinase (TIMP) and the MMP 
inhibitor (L-758,354). It was also shown by Bonassar eta/., (1997) that £L-IP 
caused an increased Joss of hyaluronan from bovine explants. Steinmeyer et a/. , 
( 1997) also showed that lL-1 a induced proteoglycan release from bovine 
metacarpophalangeal cartilage explants. This effect was inhibited by the synthetic 
MMP inhibitor Ro 31-4724. Badger eta/., (1998) showed that fL-la increased the 
production of NO, expression of iNOS and p38 mitogen activated kinase (MAP 
kinase) in bovine cartilage explants derived from the carpel metacarpel joints and 
bovine chondrocytes. Inhibition of lL-la induced p38 MAP kinase production, 
iNOS mRNA production and nitrite production was produced using SB 203580, a 
specific inhibitor of p38 MAP kinase. Hanglow et a/., (1995) showed that lL-1 p 
increased proteoglycan loss from bovine occipital cartilage explants and this was 
enhanced by L-NMMA. D'Souza et a/. , (2000) also showed that IL-Ia caused 
reduced proteoglycan incorporation into matrix formed by bovine 
metacarpophalangeal chondrocytes. These studies demonstrated that IL-l has 
many effects catabolic effects on bovine cartilage explants. 
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Studies have also been performed using lapine cartilage explants (Stefanovic-
Racic et a/., 1997) and chondrocytes (Berenbaum et a/., 1996; Jikko et a/., 1998) 
using IL-1. Stefanovic-Racic et a/., (1997) demonstrated that lapine cartilage 
explants from knee and shoulder joints produced increased levels of NO and 
suppression of proteoglycan synthesis into the explants when treated with rL-113. 
Inhibition ofNO production induced by IL-113 using L-NAME inhibited the effect 
of NO on suppression of proteoglycan synthesis, but caused increased loss of 
proteoglycans into the culture media. Jikko et a/., (1998) produced evidence that 
supported the previous study, showing that rL-113 reduced sulphate incorporation 
into GAGs in lapine knee chondrocyte cultures grown on plates coated with type I 
collagen. Berenbaum et a/., (1996) demonstrated that lapine shoulder, knee and 
femoral chondrocytes also produced PGE2 following treatment with rL-113. 
ln contrast to the aforementioned study by Stefanovic-Racic et al., (1997) using 
lapine cartilage explants, Bird et a/., ( 1997) produced contradictory data using 
equine cartilage metacarpophalengeal explants that showed inhibition of NO 
induced by IL-113 using L-NIO did not affect proteoglycan loss from cartilage 
explants. 
Studies have also been performed using rat cartilage explants in vitro (Desa et al., 
1989; Seed et a/., 1993) showed that IL-1 a did not induce release of GAGs into 
the culture media by rat femoral head cartilages. However, addition of rat neonatal 
skin fibroblasts to rat cartilage explants caused an increased loss of GAGs into the 
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culture media. Conversely, Seed et al., (1993) showed that proteoglycans were 
released from rat femoral head cartilages following treatment with IL-113 and the 
MMP inhibitor, U27391, inhibited this effect. These studies using entire rat 
femoral head cartilages showed that rat cartilage may be resistant to IL-113 
mediated catabolism in vitro. 
Studies have showed that, like rat cartilage explants, human cartilage explants 
offer resistance to IL-l mediated cartilage breakdown (Nietfield et al., 1990; Seed 
et al., 1993) showed that human femoral head cartilage explants derived from 
different patients varied in their ability to release GAGs into media following 
treatment with IL-113. N ietfield et al., ( 1990) demonstrated that human cartilage 
explants, of unstated origin in the body from autopsies, did not release increased 
concentrations of proteoglycans into the media following treatment with 20% LL-
1 a and 80% LL-113. A study by Blanco and Lotz, (1995) did, however, show that 
human femoral head chondrocyte cultures produced NO in following treatment 
with IL-113. This study also suggested that IL-113 increased chondrocyte 
proliferation via an NO and PGE2 dependent pathway. These studies demonstrate 
that human cartilage explants may have increased variability in their responses to 
treatment with IL-l due to variation of age of the patients from which they were 
obtained. Literature was also reviewed regarding the effects of TN Fa and LPS on 
cartilage explants and chondrocytes (sections 1.1.9.2 and 1.1.9.3, respectively). 
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1.1.9.2: The effects of Tumour Necrosis Factor a (TNFa) on cartilage 
explants and chondrocytes 
TN Fa is a mediator of inflammation that activates leukocytes, enhances migration 
of inflammatory cells into the extracellular matrix and triggers production of 
inflammatory cytokines (Tracey and Cerami, 1994). It may also contribute to the 
degradation of cartilage in arthritis disease. The use ofTNFa on cartilage explant 
models (Stadler et al., 1991) and chondrocytes (Berenbaum et al., 1996) has been 
limited compared to studies using IL-l~· 
Stadler eta!., (1991) showed that TNFa did not increase NO production by lapine 
knee and shoulder cartilage. Berenbaum et a/., ( 1996) demonstrated that TN Fa 
did not increase production of PGE2 in chondrocyte cultures isolated from lapine 
knee and shoulder cartilage. However, it was shown the TNFa combined with IL-
l~ increased production of NO (Stadler eta!., 1991) and PGE2 (Berenbaum et al., 
1996). These studies indicated that TNFa may increase the responsiveness of 
cartilage explants and chondrocytes to other cytokines, such as IL-l~. using in 
vitro models. Previous studies have also indicated that LPS contributes to 
production of inflammatory mediators and cartilage breakdown using in vitro 
models (section 1.1.9.3) 
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1.1.9.3: The effects of lipopolysaccharide (LPS) on cartilage explants and 
chondrocytes 
Components of the bacterial cell wall linked to infection may cause breakdown of 
the cartilage matrix by stimulation of macrophages in vivo to produce IL-113 and 
TNFa (Dinarello, 1996). Studies in vitro have also indicated that LPS may 
directly interact with cartilage explants to cause production of inflammatory 
mediators (Stadler et a!. , 1991) and loss of proteoglycans from the cartilage matrix 
(Morales eta!. , 1984; Ikebe eta!. , 1993). Stadler eta/., (1991) showed that LPS 
caused increased production of NO and PGE2 by chondrocytes isolated from 
lapine knee and shoulder cartilage. Morales et a/. , ( 1984) demonstrated that 
bovine metacarpophalangeal cartilage explants synthesised reduced levels of 
proteoglycans, increased PGE2 production and produced an increase in loss of 
proteoglycans into the culture media following treatment with LPS. Ikebe et a/. , 
(1993) showed that similar inhibition of proteoglycan synthesis occured in rat 
costal chondrocytes following treatment with LPS. The combined results of these 
studies showed that LPS may exert similar effects on cartilage explants and 
chondrocytes compared to IL-1. 
It has been shown that in RA tissue in vivo, macrophages have been identified as a 
source of IL-113, TNFa and CSFs. It has been postulated that CSFs may 
orchestrate the cellular interactions and resulting events leading to cartilage 
breakdown (Hamilton, 1993). 
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1.2.0: Colony Stimulating Factors (CSFs): a subfamily of cytokines involved 
in inflammation. 
The colony stimulating factors (CSFs) are a family of polypeptide growth factors 
critical to the development of haematopoeitic cells (Metcalf, 1989). The soluble 
colony stimulating factors include M-CSF (macrophage-colony stimulating factor, 
44KDa), G-CSF (granulocyte-colony stimulating factor, 18-22 KDa), GM-CSF 
(granulocyte macrophage-colony stimulating factor, 22KDa) and IL-3 , (also called 
multi-CSF, 14-30 KDa). Colony stimulating factors may act as differentiation 
factors initiating the irreversible terminal differentiation of progenitor cells. The 
proliferation of mature cells is usually not influenced by these factors, they may, 
however, prolong their life span. Apart from their actions on a number of 
hematopoietic cell types, CSFs also influence other cell types including those 
found within inflammatory processes Silvennoinen and Ihle, ( 1996). Indeed, CSFs 
have been used therapeutically to reduce neutropennia in Felty Syndrome (Vose 
and Armitage, 1995). 
1.2.1: A role of CSFs with other inflammatory cytokines in arthritic disease? 
It has been demonstrated that the CSFs have the ability to increase the sensitivity 
of the immune system and interact directly with a plethora of cell types 
(Nemunaitis, 1997). The role of CSFs in inflammation processes has not been 
fully characterised, however, GM-CSF I G-CSF (Campbell eta/., 1991) and M-
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CSF (Campbell et al., 1993) are produced by human cartilage and chondrocytes in 
response to stimulation with IL-lj3. IL-3 has not been demonstrated to be 
produced by cartilage to date, however, IL-3 may be produced by other cells types 
in vivo during inflammation. The main aim of this study is to determine if CSFs 
have a direct role in the regulation of cartilage catabolism and surrounding tissue 
that may exacerbate inflammation and tissue damage in vivo. Indeed, it has been 
demonstrated that GM-CSF may be upregulated by tumour necrosis factor 
a (Haworth et al., 1991) and that the GM-CSF receptor is expressed in synovial 
tissue (Berenbaum et al., 1994). Furthermore, it has also been demonstrated in a 
recent study that both M-CSF and GM-CSF exacerbate inflammation in a murine 
in vivo model of joint inflammation (Bischof et al. , 2000). 
It is possible that inflammatory mediators such as cytokines, including CSFs, may 
induce cells to produce inflammatory responses via overlapping intracellular 
signal transduction mechanisms. Thus, a link may be found between the 
functionality of cytokines in a given system due to interactions within intracellular 
signalling pathways. 
1.2.2: Cytokine Signal Transduction 
It has been shown that IL-113 induces intracellular signaling via p38 MAP kinase 
(Badger et al. , 1998) and C/CAA T enhancer binding protein (C/EBP) (Thomas et 
al. , 2000) in chondrocytes and nuclear factor kappaB (NF-KB) in inflamed 
synovial tissue (Marok et al. , 1996). It has also been shown that there is cross talk 
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between transcriptional factors NF-kB and C/EBP in the transcriptional regulation 
of genes (Xia et al. , 1997). Other cytokines such as IL-6 signal through a signal 
transducer and activator of transcription {STAT) pathway and have been shown to 
have similar effects as interleukin-1 f3 (Ochrietor et a/., 2000). Indeed, IL-6 has 
been implicated in a recent study as a mediator of proteoglycan metabolism in 
articular cartilage (Flannery et a/. , 2000). Like IL-6, G-CSF utilises an 
intracellular signaling pathway via STAT3 (Leornard and O'Shea, 1998) and that 
G-CSF activates p38 MAP kinase and extracellular signal-related kinase (ERK) 
pathways in hemopoietic cells (Rausch and Marshall, 1999). This study also 
suggests that lL-3 may also activate these signaling intermediates in hemopoietic 
cells. It is therefore possible that CSFs, such as G-CSF and IL-3, may influence 
the role of cells in the inflamed synovial joint via the aforementioned pathways. 
Cytokine signaling pathways that may influence cartilage breakdown and 
inflammation are illustrated in Fig. 1.2.2. 
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Fig. 1.2.2: Diagram showing cytokines and associated intracellular signaling 
pathways 
IL-l, TNFa, LPS, Stress 
MEKK 1/2 
ERK 1/2 p38 
c-Fos 
1 
Other 
cytokines 
&CSFs 
JAK 
STATS 
Integration of signals leading to ligand and cell type specific responses 
Fig 1.22: Diagram shows the cross talk between cytokines and the possibility of 
interactions between cytokines in producing a biological effect (diagram produced 
using Microsoft Powerpoint 97). 
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Cytokine signaling pathways have been identified as a possible therapeutic target 
for intervention in arthritic disease pathology to supress the inflammatory process. 
Indeed, both p38 MAP kinase (Lee et al. , 2000) and ERK l/2 (Firestein and 
Manning, 1999) have been suggested as possible therapeutic targets. Indeed a 
number of specific inhibitors of signal transduction intermediates have been 
produced to block signal transduction pathways. 
These include SB 203580, a pyridinylimidazole compound, that binds and inhibits 
p38 MAP kinase specifically and is suggested as efficacious in disease models of 
inflammation kinase (Lee et al. , 2000). This is supported in studies by (Badger et 
a!., 1998) and (Ridley et al., 1998) where IL-l induced iNOS expression and 
COX-2 mRNA were downregulated respectively, by SB 203580. ERK pathways 
can also be inhibited within the cell. PD 98059 is a flavone compound that binds 
to ERK l and ERK2 and may be used to inhibit cytokine and stress induced 
intracellular signalling via the ERK pathway (Cohen, 1997). PD 98059 has been 
suggested as a potential therapeutic agent in rheumatic disease since it blocks 
transduction of signals from endotoxins, IL-l p and TN F-a. (Alessi eta/. , 1995). 
The role of cytokine signalling and pathways may be evaluated by using inhibitory 
compounds such as SB 203580 and PO 98059 in conjunction with cytokines 
within models of inflammation. These compounds were obtained for use in the 
current study within a cartilage explant model system. 
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1.2.3: Objectives of this study. 
The objective of this research was to produce a model of cartilage breakdown 
using cartilage explants. The primary aim was to assess different types of cartilage 
for release of GAGs into culture media and to select a cartilage type for studies of 
GAG release generation of nitric oxide and production ofPGE2 when treated with 
IL-113, TNFa. and LPS in an in vitro model (chapter 3). It was then planned to 
review the effects of CSFs on cartilage explants (chapter 4) and to study the 
combined effects of CSFs and IL-113 on cartilage ex plants (chapter 5). 
A successive study was planned where cartilage explants were co-cultured with 
fibroblast monolayers in vitro. The aim of this study was to determine if 
fibroblasts would influence the effects of cytokines and CSFs on cartilage activity 
in vitro (chapter 7). Prior to commencing this study, fibroblast monolayers were 
analysed to measure production and release of GAGs, nitric oxide and PGE2 
modulated by cytokine and CSF treatments (chapter 6). The objective of this study 
was to provide data regarding fibroblasts interactions with cartilage explants and 
response to cytokines in the co-culture environment. 
The final aim of this project was to study intracellular signaling pathways using 
specific inhibitors involved in cytokine signaling in both fibroblasts monolayers 
and cartilage explants and identify components that may regulate chondrocyte and 
fibroblast response to cytokines (chapter 8). 
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Chapter 3: 
Establishing a cartilage explant model 
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3.1.0: Measurement of GAG release in articular and non articular cartilage 
explants 
The objective of the preliminary investigation was to produce a profile of GAG 
loss in cartilage derived from different sources. In previous studies, models using 
both articular (Seed et a/. , 1993; Hanglow et a/., 1995; Stefanovic-Racic et a/., 
1997; Bird et. a/., 1997; Sandy eta/., 1999) and non articular cartilage (Spirito et 
a/., 1995; Bottomley et al., 1997) have been used to measure in vitro GAG release 
in cartilage explant models. These studies have shown that pro-inflammatory 
mediators such as IL-113 and TNF-a. induce GAG release from cartilage explants. 
Both load bearing and non-loading bearing cartilage samples were obtained to 
compare the extent of GAG loss when cultured as in vitro explants. This study 
was performed to determine if GAG loss varied in different cartilage types under 
control culture conditions. 
Cartilage explants were dissected from human femoral heads, Male Wistar rats, 
porcine nasal and porcine podicep tissues (sections 2.1.3 & 2.1.4, respectively). 
Human femoral head cartilage explants were removed from tissue biopsies 
derived from fracture patients undergoing total hip replacement surgery (section 
2.1.5). GAG concentrations were measured in explants immediately following 
dissection by digestion with papain (section 2.2.2) and in culture media as 
described in 2.3.3. The concentration of GAGs detected is illustrated in Table. 
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3.1.0 and compares the cartilage source, amount used, cartilage type and GAG 
concentration in explants before and after 6 days of in vitro culture. The change in 
GAG concentration was expressed as % GAG loss to allow comparison of GAG 
loss from cartilage explants of varying mass. 
Table 3.1.0: Properties of cartilage explants from different sources. 
Cartilage Type 
Cartilage source Wistar rat Porcine Porcine Human 
femoral head metacarpo- Nasal femoral 
phalangeal head 
Femoral head Cartilage Cartilage Cartilage 
Amount used (150-200mg) shavings plugs shavings 
(30-40mg) (30-40mg) (20-30mg) 
Non 
Carti I age type Articular Articular Articular Articular 
GAG concentration 
(pre-culture, ).!g/ml) 480 ± 40 476 ± 78 520 ±58 356 ± 73 
GAG concentration 
(post culture, ).!g/ml) 385 ± 48 270 ± 68 279 ± 69 260 ± 64 
%GAG loss after 6 days 
of in vitro culture 20 43 46 27 
Table: 3.1.0: Cartilage ex plants (n= I 0) were used to measure percentage GAG 
loss during 6 days in culture. Wistar rat, porcine metacarpo-phalangeal and human 
cartilage explants were classified as load bearing cartilage. Porcine nasal cartilage 
was classified as non-load bearing cartilage. Porcine nasal cartilage, porcine 
metacarpo-phalangeal cartilage, and human femoral head cartilage were as 30-40 
mg explants from tissue biopsies. Pre-culture and post-culture GAG 
concentrations were expressed with± SE ofthe mean. 
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Porcine nasal cartilage and porcine metacarpo-phalangeal cartilage showed a 
significant (p<0.05) loss of total GAG concentration during 6 days in culture. 
Porcine metacarpo-phalangeal cartilage and nasal cartilage explants lost 46 % and 
43 % of GAGs respectively, during 6 days in culture. Human femoral head 
ex plants showed a loss of 27 % of total GAGs during 6 days in culture. Wistar rat 
cartilage showed a loss of 20% during 6 days in culture. GAG loss from both 
human and rat cartilage explants was less than that observed in porcine cartilage 
within control culture conditions. It was therefore concluded that rat or human 
cartilage explants would prove most useful for comparative studies on the effects 
of cytokines on GAGs release in this in vitro system. However, quantity and 
quality of cartilage explants available from human tissue samples proved to be 
highly variable during these preliminary studies, therefore rat femoral head 
cartilages were selected for use in further experiments. 
Rat cartilage explants were selected as the explant type to use in experiments 
using inflammatory mediators to stimulate an increase of GAG release. Desa eta/, 
(1989) showed that GAG content in Wistar rat cartilage explants was not affected 
by treatment with rL-la. However, a subsequent study by Seed et a/. (1993) 
showed that there was an increase in GAGs lost from rat femoral head cartilages 
in response to human recombinant lL-1 [3. IL-l f3 was therefore selected to test as a 
positive control in rat cartilage explant experiments. Rat FHC were also selected 
since they showed a low % GAG loss from cartilage explants after 6 days in 
control culture media conditions. It was considered that this would be useful when 
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differentiating GAG release mediated by inflammatory mediators from GAG 
release produced as a consequence of the in vitro explant culture method. 
3.1.1 Optimisation of the tissue culture medium 
Culture medium was initially used consisting of DMEM, HEPES buffer, 10% fetal 
calf serum (FCS), 2mM L-glutamine, I OO).!U/ml penicillin and 1 OO).!g/ml 
streptomycin. The constituents were collectively named complete supplemented 
media (CSM). DMEM was used without phenol red to allow measurement of 
GAGs released into the media using the DMB assay adapted from methodology 
described by Goldberg and Kolibas ( 1990). Absence of phenol red from the 
DMEM also allowed measurement of nitrite produced in the culture media using 
the Griess reaction adapted from methodology described by Verdon et al. (1995). 
FCS was added to maintain viability of chondrocytes within the cartilage explants 
and to supply essential nutrients and growth factors during 6 days oftissue culture. 
L-glutamine was added as an essential amino acid. Penicillin and streptomycin 
were added to reduce the potential of bacterial infection. It was noted that DMEM 
used in the explant culture contained sodium bicarbonate buffer. Therefore it was 
considered that HEPES buffer may not be essential to maintain pH in the CSM. 
This was tested by culturing rat cartilages explants in the presence and absence of 
2mM HEPES. The pH in the culture media was monitored to determine if 2mM 
HEPES buffer was a necessary additive to the CSM. The pH of the media 
following culture was compared in CSM containing 2mM HEPES and CSM 
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lacking HEPES (see Table. 3.1.1). The tissue culture media were measured to 
determine if the pH changed in CSM lacking HEPES compared to CSM 
containing 2mM HEPES. 
Table. 3.1.1: pH measurements in CSM containing 2mM HEPES buffer 
compared to HEPES free CSM. 
Media type Day 3 pH Day6 pH 
CSM+HEPES 7.2 7.1 
CSM- HEPES 7.3 7.2 
Table: 3.1.1: The presence of 2mM HEPES buffer in the CSM did not change the 
pH ofCSM compared to CSM free HEPES. 
HEPES did not cause a change or prevent a change in pH in the CSM during 
culture of rat cartilage explants for intervals of 3 days. HEPES was therefore 
omitted from the CSM for further experiments since DMEM pH was deemed to 
be sufficiently buffered by sodium bicarbonate within DMEM. Wistar FHCs were 
then cultured in optimised media to determine the effects of characterised 
proinflammatory mediators on GAG release, nitrite and PGE2 production in the 
culture media. 
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3.1.2: Effect of IL-113 on GAG concentration in post culture cartilage 
ex plants 
IL-l f3 is a soluble cytokine and proposed to be an important peptide in the 
regulation of cartilage destruction (Feldmann et al., 1996; Bird et al. , 1997). Rat 
femoral head cartilage explants were treated with 1, 10 and 50 ng/ml of IL-l f3 to 
produce a dose response curve profile. GAGs were measured in the culture media 
to determine if rat femoral head cartilage showed increase loss of GAGs from 
release when treated with IL-lj3. Nitrite production was measured in the culture 
media as a measure of NO production by treatment with lL-lj3. PGE2 
concentrations were measured in the tissue culture media to determine if COX 
activity was regulated in rat cartilage explants by IL-l f3. The concentration of 
GAGs in cartilage ex plants was measured after 6 days of tissue culture with 1, 10 
and 50ng/ml IL-l f3. The concentration of lL-1 f3 used in subsequent experiments 
was further validated by determining an IC50 value by measuring production of 
nitrite by cartilage exp1ants during 3 days (see Appendix V). The ICso value 
calculated using this technique was - 1 Ong/ml. The concentrations 1-50 ng/ml 
were also selected to compare with equivalent concentrations of lL-1 f3 used by 
Hanglow et a/. (1995), Spirito et a/. (1995), and Stefanovic-Racic eta/. (1997). 
The concentrations of GAGs in cartilage explant digests following tissue culture 
were compared in Fig. 3.1.2. 
Fig. 3.1.2: Effect of IL-1 p on GAG content in rat femoral 
head cartilage 
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Fig. 3.1.2: Rat femoral head cartilage explants (n=8) were treated as follows: 
control (A), I ng/ml IL-l f3 (B), I Ong/ml IL-l f3 (C) and 50ng/ml IL-l J3 (D) during 
a six day incubation. Culture media was changed on day 3 and cartilage GAGs 
were measured in explants following the 6 culture. Analysis of data using a 
Students t test showed that there was no significant difference was observed 
between control groups and treated groups. 
GAG concentrations in cartilages did not change following treatment with IL-l f3 
for 6 days (see Fig. 3.1.2). This experiment was repeated 3 times and produced the 
same result on each occasion. The GAG loss from cartilage explants was also 
measured in the culture media following treatment with 1, 10 and 50ng/ml of JL-
1 f3. This was measured in culture media collected on days 3 and 6 (see Fig. 3.1.3). 
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3.1.3: Effect of IL-lp on GAG concentration released in the culture media by 
cartilage explants 
Fig. 3.1.3: Effect of IL-1 p on GAG release into culture 
media from rat femoral head cartilage 
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Fig. 3.1.3: Rat femoral head cartilage explants (n=8) were treated as follows: 
control (A), I ng/ml IL-l 13 (B), I Ong/ml IL-l 13 (C) and 50ng/ml IL-l 13 (D) during 
a six day incubation. Culture media was changed on day 3. GAGs were measured 
in the culture media on days 3 and days 6. Analysis of data using a Students t test 
showed that there was no significant difference was observed between control 
groups and treated groups. 
GAG concentrations released in the tissue culture media were not changed by 
treatment with I, 10 and 50ng/ml of IL-l 13 during 6 days of culture. This was 
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surprising since research by Seed et a/. (1993) showed that human recombinant 
IL-l p induced glycosaminoglycan loss from rat FHC. It was observed that GAG 
concentrations measured in the media at day 6 were reduced compared to GAG 
concentrations measured in media collected following day 3 in both control and 
IL-l P groups. Culture media collected from these experiments were also used to 
quantify production of nitrite by rat cartilage explants. The levels of nitrite 
produced by cartilage explants were also measured and displayed in Fig. 3.1.4 as 
an indication ofNO production by chondrocytes within the cartilage matrix. 
3.1.4: Effect of IL-1(3 on concentration of nitrite produced in the culture 
media by cartilage explants 
The culture media from days 3 and day 6 were also analysed for nitrite 
concentration as a measure of nitric oxide production by rat cartilage explants. 
Studies by Stefanovic-Racic et a/. (1997) and Bird et a/. (1997) indicated that 
production of nitric oxide was increased by cartilage explants following treatment 
with IL-l p. Nitrite was measured in the media from rat FHC explant model to 
compare with these studies. Nitrite concentration was determined by the Griess 
reaction adapted from Verdon et a/ ( 1995) at days 3 and 6 in the tissue culture 
media, data obtained from this experiment are illustrated in Fig. 3.1.4. 
Fig. 3.1.4: Effect of IL-1 p on production of nitrite by rat 
femoral head cartilage 
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Fig. 3.1.4: Rat femoral head cartilage explants (n=8) were treated as follows: 
control (A), 1 ng/ml lL-113 (B), 1 Ong/ml lL-113 (C) and 50ng/ml lL-113 (D) during 
a six day incubation. Culture media was changed on day 3. Nitrite concentration 
was measured in the culture media on days 3 and days 6. Analysis of data using a 
Students t test showed that IL-113 at I, I 0 and 50 ng/ml produced a significant 
(* *P<O.O 1) increase in nitrite in the culture media after 3 days compared to 
respective same day controls. 
Nitrite concentrations in culture media were significantly (p<O.O 1) increased by 
I ng/ml, 10 ng/ml and 50 ng/ml IL-113 compared to controls after 3 days in culture. 
However, nitrite concentrations in culture media at day 6 were not significantly 
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different from controls. These results were in accordance with studies by 
Stefanovic-Racic et a/. ( 1997) and Bird et. a/. ( 1997) which suggested that 
production of nitrite was increased in cartilage explants following treatment with 
IL-113. 
The nitrite generated in the culture media by rat cartilage diminished between day 
3 and day 6. To determine how nitrite production changed with time, cartilage 
explants were placed in culture for 6 days following treatment with I Ong/ml of 
IL-113. The dose of I 0 ng/ml was selected to provide comparative data to that 
obtained in the study by Stefanovic-Racic et a/. (1997). The culture media was 
changed at 24 hour intervals and nitrite concentration was quantified to establish a 
time course of nitrite release. The results obtained are illustrated in Fig. 3 .1.5. 
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3.1.5: Effect of IL-1J3 on concentration of nitrite produced in the culture 
media by cartilage explants during a time course of 6 days 
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Fig. 3.1.5: Effect of IL-1 J3 on nitrite production by rat 
femoral head cartilage during a 6 day time course. 
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Fig. 3.1.5: A time course of nitrite production in tissue culture supernatant was 
measured during a 6 day period at 24 hour intervals following treatment of 
cartilage explants (n=6) with I 0 ng/ml of IL-l J3. Analysis of data using a Students 
t test showed that there was no significant difference between the IL-l J3 treated 
group and the control group at each time point. However, nitrite levels in both 
control and IL-1 J3 groups were highest at day 1 and had decreased by day 3. 
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Nitrite concentrations in produced in the 1 Ong/ml IL-l 13 group showed no 
significant difference from same day controls in this experiment. The 
concentration of nitrite diminished in both control and I 0 ng/ml IL-l 13 groups 
during the time course of six days. Nitrite levels were greatly reduced following 
three days in culture media. This trend was also illustrated in a study by 
Stefanovic-Racic et a/. ( 1997). On days 4, 5 and 6 both the IL-l 13 and control 
group produced concentrations of nitrite that were barely detectable using the 
Greiss reaction. The lower limit of nitrite detection using the Greiss reaction is 
approximately 2J.!M. The concentration of PGE2 was measured in media at days 1 
and 2 to compare with nitrite concentrations detected at these time intervals 
It was suggested by Stefanovic-Racic et a/. (1995) and Torzilli et a/. (1996) that 
PGE2 has a role in the regulation of GAG concentration in cartilage explants. 
PGE2 concentrations were measured in culture media at 24 hours and 48 hours 
following cartilage explant culture with IL-l 13. 
3.16: Effect of IL-lp on concentration of PGE2 produced by cartilage 
explants 
PGE2 has been correlated with regulation of cartilage GAG concentrations in 
articular cartilage (Torzilli eta/., 1996) and chondrocytes (Blanco and Lotz, 1995; 
Berenbaum et a/. , 1996). The concentration of PGE2 was determined in the rat 
cartilage explant model by measuring levels in culture media following treatment 
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with 10 ng/ml of IL-113. This concentration was selected to compare PGE2 
concentrations detected with quantified levels of nitrite as shown in Fig 3.1.5 after 
24 and 48 hours. PGE2 concentrations are illustrated in Fig. 3.1.6. 
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Fig. 3.1.6: Effect of IL-1 f3 on PGE2 production in rat 
femoral head cartilage 
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Fig. 3.1.6: Rat femoral head cartilage explants (n=8) were treated with I Ong/ml of 
IL-113 for a 48 hour incubation with a change of media at 24 hours. PGE2 
concentration was measured in the culture media and compared to controls. 
Analysis of data using a Students t test showed that PGE2 concentrations were 
significantly (P<0.05) increased in the group treated with I Ong/ml of IL-113 at 24 
and 48 hours compared to same day controls. 
109 
PGE2 concentrations were significantly (p<0.05) increased in the group treated 
with IL-l f3 compared to the control group at both 24 and 48 hours. The data 
obtained from this study was consistent with studies by Blanco and Lotz ( 1995) 
and Berenbaum et a/. (1996) which demonstrated that IL-l f3 caused increase 
production ofPGE2 in chondrocyte monolayer cultures. 
Further experiments were carried out to compare the effects ofTNF-a with IL-
l f3 with respect to concentrations of GAGs in cartilage ex plants and production of 
nitrite and PGE2• 
3.1.7: Effect of Tumour necrosis factor-a on GAG concentration in post 
culture cartilage explants 
TNFa is a soluble cytokine and proposed to be an important mediator in the 
regulation of cartilage destruction, (Homandberg et a/. , 1998; Stichtenoth and 
Frolich, 1998). Rat femoral head cartilage explants were treated with 1, 50 and 
I OOng/ml of TN F-a to produce a dose response curve profile. These 
concentrations were selected to provide comparative data to compare with studies 
by Stadler et a!. ( 1991) and Berenbaum et a/., ( 1996). 
The role of TNF-a in the rat explant model was assessed by measuring GAGs in 
the culture media and digested cartilages following culture to determine if rat 
femoral head cartilage explants showed loss of GAGs when subjected to treatment 
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with TNFa. Nitrite production was measured in the culture media as an indicator 
of NO production mediated by TNFa. PGE2 concentrations were also measured in 
the tissue culture media to determine TNFa produced similar effects to those 
observed with IL-l J3, illustrated in Fig. 3 .1.6. 
The concentration of GAGs in cartilage explants was measured after day 6 of 
tissue culture with I, 50 and I OOng/ml TNF-a. The concentrations of GAGs in 
cartilage explants digested following culture were compared in Fig. 3.1.7. 
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Fig. 3.1.7: Effect of TNF-a on GAG content in rat 
femoral head cartilage. 
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Fig. 3.1.7: Rat femoral head cartilage explants (n=8) were treated as follows: 
control (A), 1 ng/ml TN Fa (B), 50ng/ml TNFa (C) and 1 OOng/ml TNFa (D) 
during a six day incubation. Culture media were changed on day 3 and cartilage 
GAGs were measured in explants following culture. Analysis of data using a 
Students t test showed that there was no significant differences observed between 
control and treated groups. 
GAG concentrations in cartilages did not change compared to controls following 
treatment with TNFa for 6 days (see Fig. 3.1.7). The GAG loss from cartilage 
ex plants was also measured in the culture media following treatment with I, 50 
and 1 OOng/ml ofTNFa on days 3 and 6 (see Fig. 3.1 .8). 
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3.1.8: Effect of TNFa on concentration of nitrite produced in the culture 
media by cartilage explants 
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Fig. 3.1.8: Effect of TN F-a on GAG release from rat 
femoral head cartilage 
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Fig. 3.1.8: Rat femoral head cartilage explants (n=8) were treated as follows: 
control (A), lng/ml TNFa (B), 50ng/ml TNFa (C) and lOOng/ml TNFa (D) 
during a six day incubation. Culture media was changed on day 3. GAGs were 
measured in the culture media on days 3 and days 6. Analysis of data using a 
Students t test showed that there was no significant differences were observed 
between control and treated groups. 
GAG concentrations in the tissue culture media were not altered from controls by 
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treatment with I, 50 and I OOng/ml of TNF-a during 6 days of culture. It was 
observed that GAG concentrations in the media at day 6 were lower than GAG 
concentrations observed at day 3 in all groups. The culture media from days 3 and 
day 6 were also analysed for nitrite concentration to compare with GAG 
concentrations and the results obtained using IL-l J3 in a comparative study (see 
Fig. 3.1.4) Nitrite concentration at days 3 and 6 in the tissue culture media was 
displayed in Fig. 3.1.9. 
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3.1.9: Effect of TNFa on concentration of nitrite produced in the culture 
media by cartilage explants 
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Fig. 3.1.9: Effect of TN F-a. on nitrite production by rat 
femoral head cartilage. 
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Fig. 3.1.9: Rat femoral head cartilage explants (n=8) were treated as follows: 
control (A), 1 ng/ml TN Fa (B), 50ng/ml TN Fa (C) and I OOng/ml TN Fa (D) 
during a six day incubation. Culture media were changed on day 3. Nitrite 
concentration was measured in the culture media on days 3 and days 6. TNFa 
concentration of I OOng/ml caused a significant (P<0.05) increase in nitrite 
concentrations in the culture media at day 3. Analysis of data using a Students t 
test showed that there was no significant differences observed between control 
groups and treated groups. 
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Nitrite concentrations in culture media were significantly (p<0.05) increased by 
I OOng/ml TNFa compared to controls after 3 days. Nitrite concentrations in 
culture media at day 6 were not significantly different from controls. This 
compared with studies by Stadler et al. (1991) that suggested chondrocytes do not 
release nitric oxide in response to TNFa and by Badger et al. ( 1998) that 
suggested nitric oxide synthase is upregulated by TNFa. 
The nitrite generated by rat cartilage in all groups diminished between day 3 and 
day 6 (see Fig. 3. 1.9). A time course of nitrite production was established to 
determine if the production of nitrite changed with time following treatment with 
1 OOng/ml of TNFa. Culture media were changed at 24 intervals and nitrite 
concentrations were measured in the culture media using the Greiss reaction. The 
results obtained are illustrated in Fig. 3.2.0. 
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3.2.0: Effect of TNFa on concentration of nitrite produced in the culture 
media by cartilage explants during a time course of 6 days 
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Fig. 3.2.0: Effect of TN F-a on nitrite production by rat 
femoral head cartilage. 
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Fig. 3.2.0: A time course of nitrite production by rat femoral head cartilage (n=8) 
in tissue culture supernatant was measured during a six day period at 24 hour 
intervals following treatment with I OOnglml of TNFa. In this experiment there 
was no significant difference between I OOng/ml TN Fa and respective same day 
control groups. Analysis of data using a Students t test showed that there were no 
significant differences between control and treated groups. 
Nitrite concentrations produced in the I OOnglml TNFa group showed no 
significant difference from same day controls in this experiment (Fig. 3.2.0). The 
concentration of nitrite diminished in both control and I 00 ng/ml TNFa groups 
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during the time course of six days. At days 4 and day 6 the control group did not 
produce detectable concentrations of nitrite using the Griess reaction. 
PGE2 concentrations were also measured in the culture media at days l and 2 
following treatment with l OOng/ml TNFa.. This study provided data that was 
comparable with nitrite concentrations at equivalent time points. PGE2 
concentrations were illustrated in Fig. 3.2.1. 
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3.2.1: Effect of TNF-a on concentration of PGE2 produced by cartilage 
explants 
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Fig. 3.2.1: Effect of TN F-a on PGE2 production by rat 
femoral head cartilage. 
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Fig. 3.2.1: Rat femoral head cartilage explants (n=8) were treated with I OOng/ml 
of tumour necrosis factor-a for a 48 hour incubation with a change of media at 24 
hours. Analysis of data using a Students t test showed that there was no significant 
differences observed between control groups and treated groups. 
PGE2 concentrations were not significantly different in the 100 ng/ml TNFa group 
compared to the respective same day control groups. These results were consistent 
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with a study by Berenbaum eta/. (1996). A study was also performed using LPS 
(endotoxin) as an inflammatory mediator to compare its effects on cartilage 
explants with those of [L-1 !3 and TNFa. 
3.22: Effect of LPS on GAG concentration in post culture cartilage explants 
Rat femoral head cartilage explants were treated with 1, 50 and I OOJ.ig/ml of LPS 
to produce a dose response curve profile. These doses were selected to compare 
data with studies by Morales et a/. (1984) and Stadler eta/. (1991). GAGs were 
measured in the culture media to determine if rat femoral head cartilage explants 
showed loss of GAGs when treated with LPS. Nitrite production was measured in 
the culture media as a measure of NO production by LPS treatment. PGE2 
concentrations were also measured in the tissue culture media. 
The concentration of GAGs from cartilage explants digests following culture were 
measured after day 6 of tissue culture with 1, 50 and 1 OOJ.lg/ml of LPS. The 
concentrations of GAGs in cartilage explants are compared in Fig. 3.2.2. 
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Fig. 3.2.2: Rat femoral head cartilage explants (n=8) were treated as follows: 
control (A) 1J.!g/ml LPS (B), 50J.!g/ml LPS (C) and 1 OOJ.!g/ml LPS (D) for a six 
day incubation. Culture media were changed on day 3. GAGs were measured in 
the cartilage explant digests following 6 days in culture. Analysis of data using a 
Students t test showed that there were no significant differences between control 
and treated groups. 
There was no significant difference between GAG concentrations in cartilages 
following treatment with LPS for 6 days compared to controls (see Fig. 3.2.2). 
This experiment was repeated 3 times with similar results on each occasion. This 
was surprising since these results contradicted a study by Morales et a/. ( 1984) 
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that showed that LPS induced a release of proteoglycans in cartilage explant 
cultures. 
The GAGs released into the culture media from cartilage explants were also 
measured following treatment with I, 50 and I OOJ.!g/ml of LPS. This was 
measured on days 3 and 6 (see Fig. 3.2.3). 
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3.2.3: Effect of LPS on GAG release into the culture media by cartilage 
ex plants 
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Fig. 3.2.3: Effect of LPS on GAG release into culture 
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Fig. 3.2.3: Rat femoral head cartilage explants (n=8) were treated as follows: 
control (A) I J.!g/ml LPS (B), 50J.!g/ml LPS (C) and I OOJ.!g/ml LPS (D) for a 6 day 
incubation. Culture media were changed on day 3. GAGs were measured in the 
culture media on days 3 and days 6. Analysis of data using a Students t test 
showed that there were no significant differences between control and treated 
groups. 
GAG concentrations released into the tissue culture media were not changed by 
treatment with I, 50 and I OOJ.!g/ml of LPS during 6 days of culture. As in 
experiments with IL-l p (see Fig. 3.1.4 and TN F-a. (see Fig. 3.1.8), it was 
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observed that GAG concentrations in the media at day 6 were lower than GAG 
concentrations recorded at day 3 in all groups. 
Stadler et a/. ( 1991) showed that a monolayer of chondrocytes produced nitric 
oxide in response to LPS. The culture media from days 3 and day 6 were also 
analysed for nitrite concentration as a measure of nitric oxide production by rat 
cartilage explants. LPS concentrations of 1, 50 and 1 OOJ.!g/ml were used to 
compare results with previous experiments in this study. Nitrite concentrations at 
days 3 and 6 in the tissue culture media were illustrated in Fig. 3.2.4. 
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3.2.4: Effect of LPS on concentration of nitrite produced in the culture media 
by cartilage explants 
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Fig. 3.24: Effect of LPS on nitrite production by rat 
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Fig. 3.24: Rat femoral head cartilage explants derived from (n=8) were treated 
with 1Jlg/ml - 1 OOJ.!g/ml of LPS for a 6 day incubation. Culture media was 
changed on day 3. Analysis of data using a Students t test showed that there was 
no significant differences observed between control groups and treated groups. 
Observations in a study by Stadler et a/. , ( 1991) showed that increased nitrite 
production was stimulated by LPS in a monolayer of chondrocytes. However, in 
this study the observed nitrite concentrations in culture media at day 3 and 6 were 
not significantly different from same day control groups. 
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The nitrite concentration generated in the culture media by rat cartilage on day 6 
had diminished in all groups compared to nitrite concentrations detected on day 3. 
A time course of nitrite production was established to determine how the 
production of nitrite changed with time following treatment with 1 OOJ..!g/ml of 
LPS . This concentration was used to compare with the highest concentration of 
LPS used by the study by Stadler et a/. ( 1991) using a chondrocyte monolayer. 
Culture media were changed at 24h intervals and nitrite concentrations 
determined. These results were illustrated in Fig. 3.2.5. 
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Fig. 3.2.5: Effect of LPS on concentration of nitrite produced in the culture 
media by cartilage explants during a time course of 6 days 
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Fig. 3.2.5: Effect of LPS on nitrite production by rat 
femoral head cartilage during a 6 day time course. 
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Fig. 3.2.5: A time course of nitrite production by rat femoral head cartilage in 
tissue culture supernatant was measured during a six day period at 24 hour 
intervals following treatment with 100 J.!g/ml LPS. Analysis of data using a 
Students t test showed that there were no significant differences between control 
and treated groups. 
Nitrite produced in the group treated with 1 OOJ.!g/ml LPS showed no significant 
difference controls in this experiment (see Fig. 3.2.5). The concentration of nitrite 
127 
diminished in both control and I OOJ.!g/ml LPS groups during the time course of six 
days. 
In the study by Stadler eta/. (1991), PGE2 production was also increased by LPS 
in a monolayer of chondrocytes. The release of PGE2 into the culture media by rat 
cartilage explants was measured using I OOj.!g/ml LPS. PGE2 concentrations 
following treatment with LPS were illustrated in Fig. 3.2.6. 
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3.2.6: Effect of LPS on concentration of PGE2 produced by cartilage ex plants 
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Fig. 3.2.6: Effect of LPS on PGE2 production by rat 
femoral head cartilage. 
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Fig. 3.2.6: Rat femoral head cartilage explants (n=8) were treated with 1 OOJ..Lg/ml 
of LPS for a 48 hour incubation with a change of media at 24 hours. PGE2 
concentration were measured in the culture media and compared to controls. 
Analysis of data using a Students t test showed that there were no significant 
differences between control and treated groups. 
PGE2 concentrations were not significantly different in the I OOJ..Lg/ml LPS treated 
group compared to the respective same day control groups (see Fig. 3.2.6). This 
result indicated that PGE2 concentrations were not increased by LPS, 
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contradicting the study performed by Stadler et a/., ( 1991) using a chondrocyte 
monolayer system. 
The conclusion from experiments performed using lL-1 J3, TN Fa. and LPS were 
discussed in section 3.2.7 
3.2.7: Discussion of results using IL-1J3, TNFa. and LPS in a rat femoral head 
cartilages explant system 
Rat cartilage was selected for use as an explant model of cartilage breakdown. The 
rationale of selecting rat cartilage explants was that only 20 % of GAGs were lost 
from explants (Fig 3.1.0) after 6 days in control conditions. The quality and 
quantity of rat femoral head cartilages were also more consistent than human 
cartilage. Rat cartilages were also used to reduce the possibility of zonal variations 
(section 1.1.5) influencing the responses of individual cartilage explants in culture 
i.e. entire rat femoral head cartilages were used as cartilage explants. 
The ra~ femoral head cartilage explant model was tested with three pro-
inflammatory stimuli, IL-l J3, TN F-a. and LPS. These inflammatory mediators 
have all been implicated as mediators of cartilage breakdown in experimental 
models and have been shown to increase production of other markers of 
inflammation (Seed et a/., 1993; Hanglow et a/., 1995; Stefanovic-Racic et a/., 
1997; Bird et. a/., 1997; Sandy eta/., 1999; Spirito eta/., 1995 and Bottomley et 
a/., 1997). 
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In this study GAGs were measured as an indicator of cartilage breakdown. NO and 
PGE2 production were quantified as indicators of chondrocyte response to 
inflammatory mediators. IL-l~. did not produce a significant change in GAG 
concentrations in cartilage explant digests (Fig. 3.1.2) or tissue culture media 
collected from explant cultures (Fig 3.1.3). This results contradicted studies 
suggesting that IL-l~ produced increased loss of GAGs from cartilage explants 
(Seed et al., 1993; Hanglow et al., 1995; Spirito et al., 1995; Stefanovic-Racic et 
al., 1997). However, only the study by Seed et al., (1993) utilised rat cartilage 
explants as a model of cartilage breakdown. The results obtained in this study 
supported research by Desa et al. ( 1989) that showed that IL-l did not reduce 
GAG concentrations in rat cartilage explants compared to controls. 
This varied result suggests that regulation of GAGs loss from cartilage explants 
may vary in different types of cartilage and in cartilage derived from different 
species. This species variability was subsequently confirmed in a study by 
Greenwald et a!. ( 1998) that showed rats produce MMP-8, and MMP-13, but not 
MMP-1. It is therefore possible that rat cartilage therefore respond to treatment 
with IL-l~ differentially from cartilage explants derived from other species. 
Despite these reports, it is possible to produce experimental models of arthritis in 
rats in vivo using models such as dimethyl dioctadecyl ammonium bromide 
(DDA) induced arthritis (Mia et al., 2000). 
IL-l~ induced GAG loss from cartilage explants was not evident in the current 
131 
study, however, treatment with IL-113 produced a significant increase in 
production of both nitrite (Fig. 3.1.4) after 3 days and PGE2 (Fig 3.1.6) after days 
1 and 2 in the culture media. This supported previous studies that NO (Stefanovic-
Racic et al. 1997; Bird et. al. , 1997; Blanco and Lotz, 1995; Berenbaum et al. , 
1996) production were mediated by IL-113 in cartilage explant studies. 
TNFa. has been implicated as an important mediator of inflammation and cartilage 
breakdown (Homandberg et al. , 1998; Stichtenoth and Frolich, 1998), although it 
has not been directly linked to reduction of GAG concentrations in rat cartilage 
explant models. In this study TNFa did not affect GAG profiles in cartilage 
explants digests (Fig. 3.1 .7) or in collected culture media (Fig 3.1.8). However, 
100 ng/ml of TNFa produced a significant elevation in production of nitrite 
(Fig. 3.19) after 3 days in the culture media. This contradicted a report by Stadler 
et al. , ( 1991) that suggested lapine chondrocytes do not release nitric oxide in 
response to TNFa. However, a study by Badger et al., (1998) showed that nitric 
oxide synthase is upregulated by TNFa in bovine chondrocytes. This suggests that 
chondrocytes derived from different species respond differentially to TNF-a. The 
method of using chondrocytes in a monolayer culture may also alter their 
responsiveness to inflammatory mediators such as TNFa and IL-113. 
Ln the present study it was shown that only the highest concentration ( 1 00 ng/ml) 
of TN Fa (I 00 ng/ml) used resulted in increased production of nitrite and that 
TNF -a was less potent than IL-113 as a mediator of nitrite production at equivalent 
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concentrations. Unlike IL-113, TNFa failed to influence the production of PGE2 
(Fig 3.2.1) by rat cartilage explants. These results were supported in a study 
performed by Berenbaum et al., (1996) that showed chondrocyte monolayers do 
not produce PGE2 in response to TNF-a treatment. 
A study by Morales et al., (1984) suggested LPS was a mediator of GAG loss 
from bovine cartilage explants. Stadler et al. , ( 1991) produced a study that 
suggested LPS mediated production of both NO and PGE2 from lapine 
chondrocyte monolayers. However, in the current study LPS did not significantly 
change GAG concentrations in cartilage explant digests (Fig. 3.2.2), GAG 
concentrations in media (Fig. 3.2.3), or production of nitrite (Fig 3.2.5) and PGE2 
(Fig. 3.2.6) by cartilage explants. These apparent deviations from the dogma that 
LPS mediates cartilage breakdown may have been a result of cartilage species 
variability in response to treatment with inflammatory mediators. Stadler, (1991) 
used lapine chondrocytes and Morales, (1984) used bovine explants as compared 
to this model where rat cartilage explants were used. 
In this study, IL-113 proved to be the most potent inflammatory mediator with 
respect to increased production of nitrite and PGE2. Since IL-113 increased release 
of nitrite and PGE2 into the culture media from rat cartilage, it was selected as a 
positive control stimulus in the model to compare with the effects of CSFs on rat 
cartilage explants (see chapter 4). 
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Chapter 4: 
Effects of colony stimulating factors on rat 
femoral head cartilage explants. 
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4.1.0 Introduction 
Colony stimulating factors (CSFs) have been identified as inflammatory mediators 
that are produced by chondrocytes (Campbell et a/. , 1991 ; Campbell et a/. , 1993) 
and human synovial fibroblasts (Hamilton et a/., 1993). However, the effect of 
CSFs on cartilage has not been elucidated. The objective of this study was to 
determine if the CSFs regulated cartilage explants activity with respect to GAG 
content, nitrite and PGE2 production. ln the previous study (see chapter 3) the 
effects of IL-113, TNF-a and LPS were measured with respect to regulation of 
GAG content and release by rat femoral head cartilage. The effects of IL-lj3, 
TNF-a and LPS were also assessed with respect to PGE2 and NO production. IL-
l f3 was established as a positive control with respect to nitrite and PGE2 
production by cartilage explants. The effects of CSFs on regulation of GAGs, NO 
and PGE2 in cartilage explants were measured and compared to lL-lj3. 
To determine if CSFs directly regulate chondrocyte activity, a series of 
experiments were performed to measure GAG content in cartilages following 
culture and loss of GAGs into the culture media at days 3 and 6 during a 6 day 
culture. Release of nitrite at days 3 and 6 and release of PGE2 into the culture 
media at days I and 2 were also measured following treatment with CSFs. Since 
concentrations of CSFs produced by cartilage and surrounding tissues in the 
synovial joint have not been determined, a dose response was measured with each 
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G-CSF, GM-CSF, M-CSF and lL-3 at l, l 0 and 50 ng/ml. This provided data that 
were comparable with those obtained using equivalent concentrations of lL-1 ~ 
(see chapter 3). 
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4.1.1 Effect of G-CSF on GAG concentration in post culture cartilage 
explants 
Fig. 4.1.1: Effect of G-CSF on GAG content in rat 
femoral head cartilage 
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Fig. 4.1.1: Rat femoral head cartilage explants (n=8) were treated as follows: 
control (A), 1 ng/ml G-CSF (B), 1 Ong/ml G-CSF (B) and 50 ng/ml G-CSF (C) for 
a six day incubation. Culture media were changed on day 3. GAGs concentrations 
were measured in the cartilage explant digests following the 6 day culture. 
Analysis of data using a Students t test showed showed that G-CSF at 10 ng/ml a 
produced a significant (*P<0.05) reduction in GAG concentrations in group C 
compared to the control (group A). 
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GAG concentrations in cartilages showed no significant difference compared to 
controls following treatment with I ng/ml and 50ng/ml G-CSF for 6 days, however 
treatment with 10 ng/ml of G-CSF reduced levels of GAGs in the cartilage 
digests. GAG loss from cartilage explants was also measured in the culture media 
following treatment with 1, 10 and 50 ng/ml of G-CSF. This was measured on 
days 3 and 6 (see Fig. 4.1 .2). 
4.1.2 Effect of G-CSF on GAG concentration released in the culture media by 
cartilage explants 
Rat femoral head cartilage explants (n=8) were treated with 1, l Ong/ml and 50 
ng/ml of G-CSF for a six day incubation. Culture media were changed on day 3. 
GAG concentrations were measured in the culture media collected on days 3 and 
days 6. Analysis of data using a Students t test showed that there was no 
significant difference observed between control and treated groups. It was 
observed that GAG concentrations in the media at day 6 were lower than GAG 
concentrations recorded at day 3 in all groups. 
The culture media from days 3 and 6 were also analysed for nitrite concentration 
as a measure of nitric oxide production by rat cartilage explants. Nitrite 
concentrations at days 3 and 6 in the tissue culture media are illustrated in 
Fig. 4.1.3. 
138 
4.1.3: Effect of G-CSF on concentration of nitrite produced in the culture 
cartilage explants 
Fig. 4.1.3 Effect of G-CSF on production of nitrite by rat 
femoral head cartilage 
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Fig. 4.1.3: Rat femoral head cartilage explants (n=8) were treated as follows: 
control (A), 1 ng/ml (B) G-CSF, I Ong/ml G-CSF (C) and 50 ng/ml of G-CSF (D) 
for a six day incubation. Culture media were changed on day 3. Nitrite 
concentrations were measured in the culture media collected on days 3 and days 6. 
Analysis of data using a Students t test showed showed that G-CSF at 1 ng/ml 
caused a significant increase in nitrite concentration in groups C (*P<0.05) and D 
(*P<O.OS) after 3 days compared to respective controls. G-CSF produced a 
significant increase in nitrite concentrations in group B (**P<O.Ol), C (*P<0.05) 
and D (*P<0.05) compared to the control (group A) after 6 days. 
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Nitrite concentrations in culture media were significantly increased by 1 0 ng/ml 
(p<0.05) and 50 ng/ml IL-l p (p<0.05) compared to same day controls after 3 days. 
Nitrite concentrations in culture media at day 6 were significantly increased by 
lng/ml (p<O.Ol), IOng/ml G-CSF (p<0.05) and 50ng/ml (p<0.05) compared to 
respective same day controls. 
A time course of nitrite production during 6 days was established to elucidate how 
the production of nitrite changed with time following treatment with 1 Ong/ml of 
G-CSF. This concentration was selected to provide comparable data with that 
derived from time course experiments using IL-l p (see chapter 3). Culture media 
was changed at 24 intervals and nitrite concentratio21\ms measured in the culture 
media samples using the Griess reaction. These results are illustrated in Fig. 4.1.4 
as cumulative nitrite concentration. 
4.1.4 Effect of G-CSF on concentration of nitrite produced in the culture 
media by cartilage ex plants during a time course of 6 days 
A time course of nitrite concentrations produced by rat femoral head cartilages 
(n=8) in tissue culture media were measured during a six day period at 24 hour 
intervals following stimulation with 1 Ong/ml G-CSF. Analysis of data using a 
Students t test showed that there was no significant difference was produced in the 
I Ong/ml G-CSF group compared to respective control groups. 
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PGE2 concentrations were also measured in the culture media following treatment 
with 10 ng/ml G-CSF. This concentration and duration of culture was selected to 
allow direct comparison with equivalent IL-l [3 data obtained (see chapter 3). 
PGE2 concentrations were measured in the culture media at days 1 and 2 
following treatment with G-CSF. PGE2 concentrations were illustrated in Fig. 
4.1.5. 
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4.1.5: Effect of G-CSF on concentration of PGE2 produced by cartilage 
explants 
6.00 
c 5.00 cu 
C1) 
E 
C1) 
.c 4.00 
-
-
0 
w 
en 
I 3.00 
-+ 
-E 
c, 2.00 
c 
-N 
w 
~ 1.00 
0.00 
Fig. 4.1.5: Effect of G-CSF on PGE2 production by rat 
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Fig. 4.1.5: Rat femoral head cartilage explants (n=8) were treated with I Ong/ml 
G-CSF for a 48 hour incubation with a change of media at 24 hours. PGE2 
concentrations were measured in the culture media and compared to controls. 
Analysis of data using a Students t test showed showed that G-CSF at I 0 ng/ml 
produced significant increase (p<O.OS) on day 1 compared to the same day control 
group. 
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The group of cartilage explants treated with I 0 ng/ml G-CSF showed a significant 
(p<0.05) increase in concentration of PGE2 in the culture media after day I 
compared to the same day control group. There was no significant difference 
observed between the I Ong/ml G-CSF group and control group at 48 hours. 
Experiments were also performed by treating cartilage explants with GM-CSF to 
provide comparative data with G-CSF and IL-l~-
4.1.6: Effect of GM-CSF on GAG concentration in post culture cartilage 
ex plants 
Rat femoral head cartilage explants (n=8) were treated with I ng/ml, I Ong/ml and 
50 ng/ml GM-CSF for a six day incubation. Culture media were changed on day 3. 
GAG concentrations were measured in the cartilage explant digests following the 
6 days of culture. Analysis of data using a Students t test showed that there was no 
significant difference was observed between same day control and treatment 
groups. 
The GAG loss from cartilage explants was also measured in the culture media 
collected following treatment with I, I 0 and 50ng/ml of GM-CSF. This was 
measured following days 3 and 6 of culture. 
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4.1.7 Effect of GM-CSF on GAG concentration released in the culture media 
by cartilage explants 
Rat femoral head cartilage explants (n=8) were treated with I ng/ml, I Ong/ml and 
50 ng/ml GM-CSF for a six day incubation. Culture media were changed on day 3. 
GAG concentrations were measured in the culture media collected on days 3 and 
days 6. As with G-CSF, analysis of data using a Students T test showed that there 
was no significant difference was observed between control and and treatment 
groups. As in previous experiments, it was observed that GAG concentrations in 
the media at day 6 were lower than GAG concentrations recorded at day 3 in all 
groups. The culture media from days 3 and 6 were also analysed for nitrite 
concentration as a measure of nitric oxide production by treatment with GM-CSF. 
4.1.8: Effect of GM-CSF on concentration of nitrite produced in the culture 
media by cartilage explants 
Rat femoral head cartilage explants (n=8) were treated with 1 ng/ml, 1 Ong/ml and 
50 ng/ml GM-CSF for a six day incubation. Culture media were changed on day 3. 
Nitrite concentrations were measured in the culture media collected on days 3 and 
days 6. However, unlike treatment with G-CSF, analysis of data using a Students t 
test showed that there was no significant difference was observed between 
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GM-CSF treated group and same day control. As in previous experiments, nitrite 
generated in the culture media by rat cartilage diminished between day 3 and day 6 
in both control and treated groups. 
PGE2 concentrations were measured in the culture media following treatment with 
10 ng/ml GM-CSF. PGE2 concentrations were measured in the culture media at 
days 1 and 2. This concentration and duration of culture were selected to provide 
comparative data with that obtained from previous experiments with IL-l f3 and 
G-CSF data. 
4.1.9: Effect of GM-CSF on concentration of PGE2 produced by cartilage 
ex plants 
There was no significant difference observed between the I Ong/ml GM-CSF 
treated cartilage explants and control group. PGE2 concentrations in collected 
culture media after days 1 and 2. Experiments were then performed by treating 
cartilage explants with M-CSF to provide comparative data with G-CSF, GM-CSF 
and TL-1 f3. 
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4.2.0: Effect of M-CSF on GAG concentration in post culture cartilage 
ex plants 
Rat femoral head cartilage explants (n=8) were treated with lng/ml, IOng/ml and 
50 ng/ml M-CSF for a six day incubation. Culture media were changed on day 3. 
GAG concentrations were measured in the cartilage explant digests following the 
6 day culture. Analysis of data using a Students t test showed that there was no 
significant difference was observed between the control and treatment groups. The 
GAG loss from cartilage explants was also measured in the culture media on day 3 
and 6 following treatment with I, 10 and 50ng/ml ofM-CSF. 
4.2.1: Effect of M-CSF on GAG concentration released in the culture media 
by cartilage explants 
Rat femoral head cartilage explants (n=8) were treated with I ng/ml, I Ong/ml and 
50 ng/ml M-CSF for a six day incubation. Culture media were changed on day 3. 
GAG concentrations were measured in the culture media collected on day 3 and 6. 
Analysis of data using a Students t test showed that there was no significant 
difference was observed between the control and treated groups. It was observed 
that GAG concentrations in the media at day 6 were lower than GAG 
concentrations recorded at day 3 in both control and treatment groups. The culture 
media from day 3 and 6 were also analysed for nitrite concentration as a measure 
of nitric oxide production mediated by M-CSF. 
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4.2.2: Effect of M-CSF on concentration of nitrite produced in the culture 
media by cartilage explants 
Rat femoral head cartilage explants (n=8) were treated with I ng/ml, I Ong/ml and 
50 ng/ml M-CSF for a six day incubation. Culture media were changed on day 3. 
Nitrite concentrations were measured in the culture media collected on day 3 and 
6. Analysis of data using a Students t test showed that there was no significant 
difference observed between the control and treatment groups. The nitrite 
generated in the culture media by rat cartilage diminished between day 3 and 6. 
PGE2 concentrations were measured in the culture media at days I and 2 
following treatment with 10 ng/ml M-CSF. 
4
.2.3: Effect of M-CSF on concentration of PGE2 produced by cartilage 
explants 
Rat femoral head cartilage explants (n=8) were treated with I Ong/ml of M-CSF 
for a 2 day incubation with a change of media at day 1. PGE2 concentrations were 
measured in the culture media and compared to controls. Analysis of data using a 
Students t test showed that there was no significant difference observed between 
the control and treatment group. Experiments were then performed by treating 
cartilage explants with JL-3 to provide comparative data with G-CSF, GM-CSF, 
M-CSF and IL-l (3 . 
147 
4.2.4: Effect of IL-3 on GAG concentration in post culture cartilage explants 
Rat femoral head cartilage explants (n=8) were treated with I ng/ml, I Ong/ml and 
50 ng/ml IL-3 for a six day incubation period. Culture media were changed on day 
3. GAG concentrations were measured in the cartilage explant digests following 
the 6 day culture. Analysis of data using a Students t test showed that there was no 
significant difference observed between control and treatment groups. GAG loss 
from cartilage explants was also measured in the culture media following 
treatment with I, I 0 and 50ng/ml IL-3. 
4.2.5: Effect of IL-3 on GAG concentration released in the culture media by 
cartilage explants 
Rat femoral head cartilage explants (n=8) were treated with I ng/ml, I Ong/ml and 
50 ng/ml IL-3 for a six day incubation. Culture media were changed on day 3. 
GAG concentrations were measured in the culture media collected on day 3 and 6. 
Analysis of data using a Students t test showed that there was no significant 
difference was observed between control and and treatment groups. As in previous 
experiments, it was observed that GAG concentrations in the media at day 6 were 
lower than GAG concentrations recorded at day 3 in all groups. The culture media 
from day 3 and 6 were also analysed for nitrite concentration as a measure of nitric 
oxide production mediated by IL-3. 
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4.2.6: Effect of IL-3 on concentration of nitrite produced in the culture media 
by cartilage explants 
Rat femoral head cartilage explants (n=8) were treated with lng/ml, 10ng/ml and 
50 ng/ml IL-3 for a six day incubation. Culture media were changed on day 3. 
Nitrite concentrations were measured in the culture media on day 3 and 6. 
Analysis of data using a Students t test showed that there was no significant 
difference observed between control and treated groups. The nitrite generated in 
the culture media by rat cartilage diminished between day 3 and 6. PGE2 
concentrations were also measured in the culture media following treatment with 
I 0 ng/ml IL-3. PGE2 concentrations were measured in the culture media at day 1 
and 2 and are illustrated in Fig 4.2.6. 
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4.2.6: Effect of IL-3 on concentration of PGE2 produced by cartilage explants 
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Fig. 4.2.6: Effect of IL-3 on PGE2 production by rat 
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Fig. 4.2.6: Rat femoral head cartilage explants (n=8) were treated with 1 Ong/ml of 
IL-3 for a 48 hour hour incubation with a change of media at 24 hours. PGE2 
concentrations were measured in the culture media and compared to controls. 
Analysis of data using a Students t test showed showed that IL-3 at 10 ng/ml a 
produced significant increase (p<0.05) on day 2 compared to the same day control 
group. 
There was a significant increase (p<0.05) in concentrations of PGE2 in the group 
treated with IL-3 compared to the same day control group following day 2 in 
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culture. However, there was no significant difference observed between control 
and treatment groups following day 1 of culture. 
4.2.7: Discussion comparing effects of CSFs on rat femoral head cartilage 
compared to IL-1(3 
Studies by Campbell et al. ( 1991 and 1993) have shown that cartilage explants 
produce CSFs in response to IL-l p. A study by Bischof et al., (2000) showed that 
both M-CSF, also known as CSF-1 , and GM-CSF exacerbated the inflammatory 
arthritis in an acute methylated bovine serum albumin (mBSA)-induced murine 
arthritis model when administered systemically. However, the direct action of 
CSFs on cartilage has not been characterised. The present investigation produced 
data that showed the effects of CSFs on NO production, PGE2 production and 
GAG concentrations in rat cartilage explants and culture media. Cartilage explants 
were treated with G-CSF, GM-CSF, M-CSF and IL-3 and compared with the 
effects of IL-l p (see chapter 3). 
Treatment of cartilages with G-CSF at concentrations of 1, 10 and 50 ng/ml 
caused a significant increase in both nitrite (Fig. 4.1 .1) and PGE2 (Fig. 4.1.3) 
concentrations produced by rat cartilage explants. G-CSF also produced a 
significant (p<0.05) reduction in GAG concentrations (Fig. 4.1.5) detected in rat 
cartilage explant digests. Both G-CSF and IL-l P increased nitrite and PGE2 
levels, though unlike G-CSF, IL-l p did not reduce GAG levels in cartilage explant 
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digests. However, despite the reduction of GAG concentrations in explants treated 
with G-CSF, GAGs were not elevated in the culture media following treatment 
with G-CSF. Since GAGs were not lost from G-CSF explants, it was speculated 
that G-CSF may have reduced GAG synthesis or GAG incorporation into the 
cartilage matrix. 
Unlike G-CSF, GM-CSF and M-CSF did not cause a change in production of 
nitrite, PGE2 or GAG levels following administration to cartilage explants. 
However lL-3, also known as multi-CSF, produced a significant increase m 
concentrations of PGE2 produced in the culture media by rat cartilage explants. 
Since studies by Campbell et a/. ( 1991 and 1993) suggested that IL-113 caused 
production of CSFs by cartilage ex plants and chondrocytes, it was rationalised that 
CSFs and IL-113 may be localised around cartilage and chondrocytes when 
considering an in vivo inflammatory response. Therefore, effects of combining 
treatments of CSFs with IL-113 on rat cartilage explants were examined in the 
following study (Chapter 5). 
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Chapter 5: 
The effects of CSFs combined with IL-lB on 
rat femoral head cartilage explants. 
153 
5.1.0: Introduction 
The results ofthe previous investigation (chapter 3) demonstrated that IL-113 is the 
most potent inflammatory mediator with respect to nitrite and PGE2 production by 
rat femoral head cartilage explants, compared to TNF-a and LPS. The results 
displayed in chapter 4 showed that G-CSF also increased production of nitrite and 
PGE2 by rat cartilage explants and G-CSF also influenced GAG concentrations in 
cartilage explant digests. Treatment of cartilage explants with IL-3 caused an 
increased production ofPGE2• Campbell et al. (1991 and 1993) showed that IL-113 
caused production of CSFs by cartilage explants and chondrocytes and Bischof et 
al. (2000) showed that CSF may influence an experimental murine model of 
arthritis. Therefore, a study was performed to examine the combined effects of 
IL-113 with CSFs on the rat cartilage explant model system. 
A study was performed by combining treatments of CSFs with IL-113 to determine 
if the combined effect of the CSFs with IL-113 was greater or less than individual 
effects of these cytokines in rat cartilage explants. As in previous investigations, 
GAG concentrations in cartilage explant digests and culture media were 
determined and concentrations of nitrite and PGE2 released into the culture media 
were also measured. 
[n the present study lL- 113 used were used at a concentration of 10 ng/ml to 
provide comparative data with those illustrated in chapters 3 and 4. CSFs were 
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used at a concentration of I Ong/ml since G-CSF and IL-3 were demonstrated to 
have regulatory effects on cartilage at these concentrations (see chapter 4). GAG 
concentrations in cartilage explant digests were determined, as previously 
described following a 6 day culture period with a change of culture media at 24 
hour intervals. Media samples were collected at 24 hours intervals and analysed to 
determine a time course of nitrite production during 6 days. GAG concentrations 
were measured the culture media from days 1 and 2 in this study. This provided 
data that could be compared with both nitrite and PGE2 concentrations in sample 
media collected on days 1 and 2. These parameters were quantified following 
combined treatments with G-CSF and IL-l~ (see 5.1.1 - 5.1.4). 
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5.1.1: Effect of G-CSF and IL-113 on GAG concentration in post culture 
cartilage explants 
Fig. 5.1.1: Effect of G-CSF and IL-1 13 on GAG content in 
rat femoral head cartilage 
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Fig. 5.1.1: Rat femoral head cartilage explants (n=8) were treated with 10ng/ml 
G-CSF and 1 0 ng/ml TL-113 for a six day incubation. Culture media were collected 
at 24 hour intervals. GAG concentrations were measured in rat cartilage explant 
digests following the 6 day culture. Analysis of data using a Students t test showed 
showed that G-CSF and 1L-113 produced a significant (*= P<0.05) reduction in 
GAG concentrations compared to the control group. 
GAG concentrations in cartilages were significantly reduced (p<0.05) following 
treatment with G-CSF and 1L-113 for 6 days compared to the control group. This 
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effect was similar to that observed following treatment with G-CSF alone (see Fig. 
4.11 )., the combined effect of G-CSF and IL-113 was comparable to that of G-CSF 
alone. GAG Joss from cartilage explants was also measured in the culture media 
collected following treatment with G-CSF and IL-113. This was measured in media 
collected from days 1 and 2 (see Fig. 5.1.2). 
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5.1.2: Effect of G-CSF and IL-l~ on GAG concentration released in the 
culture media by cartilage explants 
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Fig. 5.1.2: Effect of G-CSF and IL-1 ~ on GAG release by 
rat femoral head cartilage 
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Fig. 5.1.2: Rat femoral head cartilage explants (n=8) were treated with 1 Ong/ml 
G-CSF and I 0 ng/ml fL-113 for a six day incubation period. GAGs were measured 
in the culture media collected on days I and days 2. Analysis of data using a 
Students t test showed that G-CSF and lL-113 caused a significant (*P<0.05) 
increase in GAG concentrations in the media on day I compared to the same day 
control group. 
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GAG concentrations in the tissue culture media were significantly increased on 
day I following treatment with G-CSF and IL-113 during 6 days of culture. This is 
compared to media samples collected after 3 and 6 days from individual 
treatments with JL-113 and G-CSF that did not cause elevated concentrations of 
GAGs in media compared to controls. This demonstrated that combined treatment 
with IL-113 and G-CSF had a significant effect on GAG loss from cartilage 
explants compared to separate treatments with IL-113 and G-CSF. The culture 
media from days 1-6 were also analysed for nitrite during a 6 day time course. 
Cumulative nitrite concentration in the tissue culture media was displayed in Fig. 
5.1.3. 
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5.1.3: Effect of G-CSF and IL-lP on cumulative concentration of nitrite 
produced in the culture media by cartilage explants during a time course of 6 
days 
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Fig. 5.1.3: Effect of G-CSF and IL-1 p on nitrite production 
by rat femoral head cartilage during a 6 day time course. 
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Fig. 5.1.3: A time course of cumulative nitrite production by rat femoral head 
cartilage explants (n=8) in tissue culture media was measured during a six day 
period at 24 hour intervals following stimulation with I 0 ng/ml of G-CSF and I 0 
ng/ml of lL-113. Analysis of data using a Students t test showed that G-CSF and 
lL-113 caused a significant (*p<0.05) increase in nitrite concentrations in the media 
on days 2, 3, 4, 5 and 6 compared to the same day control group. 
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Nitrite concentrations in culture media were significantly increased by combined 
treatment with G-CSF and IL-l p (p<0.05) compared to same day controls on days 
2, 3, 4, 5 and 6. In previous experiments, individual treatments with IL-l p 
(Fig. 3.1.5) and G-CSF (section 4.1.4) did not cause a significant increase in 
concentrations of nitrite measured in media at 24 hour intevals during a 6 day time 
course. However, individual treatments with IL-l p (Fig. 3.1.4) and G-CSF 
(Fig 4.1.3) culture caused significant increases of nitrite levels in culture media at 
day 3 and day 6 during a six day culture period. Nitrite concentrations were 
compared to PGE2 concentrations at day 1 and 2 in culture media following 
combined treatment with G-CSF and IL-l p. The results obtained are illustrated in 
Fig. 5.1.4. 
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5.1.4: Effect of G-CSF and IL-113 on concentration of PGE2 produced by 
cartilage explants 
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Fig. 5.1.4: Rat femoral head cartilage explants (n=8) were treated with 1 Ong/ml of 
G-CSF and I 0 ng/ml IL-l 13 for a 48 hour incubation period with a change of 
culture media at 24 hours. PGE2 concentrations were measured in the culture 
media on days 1 and 2. Analysis of data using a Students t test showed that G-CSF 
and IL-113 caused a significant (*P<0.05) increase in PGE2 concentrations in the 
media on days I and 2 compared to the same day control group. 
The group of cartilage explants treated with G-CSF and IL-113 showed a 
significant (p<0.05) increase in concentration of PGE2 in the culture media after 
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day 1 a nd day 2 compared to the same day contro l gro up. In previo us experiments, 
individual treatments with IL- l~ (Fig. 3. 1.6) and G- F (Fi l 5) cau ed a 
igni ·fi ca nt increase in concentration of PO ·2 measured in media samples at days 
I and 2. Treatment with both G-CSF and IL- l ~ resulted in a significant increases 
in POE2 concentrations on days l and 2 how v r PGE2 cone ntrati n in th 
combined study were not s ignillcantly e levated compared to those detected in the 
individual studies. The combined effects of GM-CSF and IL- l~ on rat cartilage 
explants were determined in sections 5. 1.5 - 5.1.8 and compared with th- ffe t 
observed in the combined study with G-CSF and IL- l f3 . 
5.1.5: Effect of GM-CSF and IL-1J3 on GAG concentration in post culture 
cartilage explants 
Rat femoral head cartilage explants (n=8) were treated with 1 Ong/ml GM-CSF and 
1 0 ng/ml IL-113 for a six day incubation. Culture media were changed at 24 hour 
intervals. GAG concentrations were measured in rat cartilage explant digests 
following the 6 day culture. Analysis of data using a Students t test showed that 
there was no significant difference between the control and treatment groups. 
GAG concentrations were also measured in culture media collected on days 1 and 
2. 
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5.1.6 Effect of GM-CSF and IL-1J3 on GAG concentration released in the 
culture media by cartilage explants 
Rat femoral head cartilage explants (n=8) were treated with 1 Ong/ml GM-CSF and 
I 0 ng/ml IL-l f3 for a six day incubation. GAGs concentrations were measured in 
culture media collected on days 1 and days 2. Analysis of data using a Students t 
test showed that there was no significant difference observed between the control 
and treatment groups. Nitrite concentrations in culture media collected at 24 hour 
intervals in a 6 day culture period were also measured. 
5.1.7: Effect of GM-CSF and IL-1J3 on nitrite produced in the culture media 
by cartilage explants during a time course of 6 days 
A time course of nitrite production by rat femoral head cartilage (n=8) in tissue 
culture supernatant was measured during a six day period at 24 hour intervals 
following stimulation with 10 ng/ml of GM-CSF and 10 ng/ml of IL-l f3. Analysis 
of data using a Students t test showed that there was no significant difference 
between the control and and treatment groups. PGE2 concentrations were 
measured in culture media at day 1 and 2 following combined treatment with 
GM-CSF and fL-1 f3 and compared with nitrite and GAG data. 
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5.1.8: Effect of GM-CSF and IL-lf3 on concentration of PGE2 produced by 
cartilage explants 
Fig 5.1.8: Effect of GM-CSF and IL-113 on PGE2 production 
by rat femoral head cartilage 
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Fig. 5.1.8: Rat femoral head cartilage explants (n=8) were treated with I 0 ng/ml 
of GM-CSF and I 0 ng/ml IL-113 for a 48 hour incubation period with a change of 
media at 24 hours. PGE2 concentrations were measured in the culture media and 
compared to controls. Analysis of data using a Students t test showed that 
GM-CSF and fL-113 caused a significant (***P<O.OOI) increase in PGE2 
concentrations in the media on day 2 compared to the same day control group. 
The group of cartilage explants treated with GM-CSF and IL-l 13 showed a 
significant (p<O.OO I) increase in concentration of PGE2 in the culture media after 
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day 2 compared to the same day control group. In a previous study, treatment with 
IL-l f3 (Fig 3.1.6) resulted in a significant increase in PGE2 concentrations 
produced by rat cartilage explants in culture media. However, GM-CSF did not 
increase production of PGE2 (see section 4.1.9). However, combined treatment of 
explants with GM-CSF and IL-l f3 caused production of PGE2 at a higher 
concentration (18.96 ± 3.18 ng/ml of PGE2) than the combined concentrations 
generated by individual treatments with GM-CSF (4.32 ± 1.45 ng/ml of PGE2) 
and IL-l~ (2.4 7 ± 0.17 ng/ml of PGE2) following day 2. These results showed 
that combined GM-CSF and IL-l~ increased production of PGE2 compared to 
treatment with IL-l ~. 
The combined effects of M-CSF and lL-1 ~ on rat cartilage explants were also 
determined (see sections 5.1.9-5.2.3) and compared with data in the previous 
studies using CSFs and IL-l f3. 
5.1.9: Effect of M-CSF and IL-lp on GAG concentration in post culture 
cartilage explants 
Rat femoral head cartilage ex plants (n=8) were treated with I Ong/ml M-CSF and 
10 ng/ml IL-1 ~ for a six day incubation period. Culture media were changed at 24 
hour intervals. GAG concentrations were measured in rat cartilage explant digests 
following the 6 day culture. Analysis of data using a Students t test showed that 
there was no significant difference between the control and treatment groups. 
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GAG concentrations were also measured in culture media collected on days I and 
2. 
5.2.0: Effect of M-CSF and IL-lf3 on GAG concentration released in the 
culture media by cartilage explants 
Rat femoral head cartilage explants (n=8) were treated with 1 Ong/ml M-CSF and 
10 ng/ml IL-l f3 for a six day incubation period. GAGs were measured in the 
culture media collected on days 1 and 2. As in the previous study using GM-CSF, 
analysis of data using a Students t test showed that there was no significant 
difference observed between the control and treatment groups. Nitrite 
concentrations were also measured in culture media samples collected at 24 hour 
intervals during a 6 day culture period. 
5.2.1: Effect of M-CSF and IL-lf3 on nitrite produced in the culture media by 
cartilage explants during a time course of 6 days 
A time course of nitrite production by rat femoral head cartilages (n=8) in tissue 
culture supernatant was measured during a six day period at 24 hour intervals 
following stimulation with 10 ng/ml of M-CSF and 10 ng/ml of IL-113. As in the 
previous study using GM-CSF, analysis of data using a Students t test showed that 
167 
there was no significant difference observed between the control and and 
treatment groups. PGE2 concentrations were also quantified in culture media at 
days 1 and 2 following combined treatment with M-CSF and IL-l~· 
5.2.2: Effect ofM-CSF and IL-lp on ofPGE2 produced by cartilage explants 
Rat femoral head cartilage explants (n=8) were treated with 1 Ong/ml of M-CSF 
and 10 ng/ml lL-1 ~ for a 2 day period with a change of media at 24 hours. PGE2 
concentration was measured in the culture media and compared to control groups. 
Analysis of data using a Students t test showed that there was no significant 
difference between the control group and treatment groups. 
The combined effects of IL-3 and IL-l~ on rat cartilage explants were determined 
in sections 5.2.3-5.2.7 and compared with data in the previous combined studies 
using CSFs and lL-1 ~· 
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5.2.3: Effect of IL-3 and IL-113 on GAG concentration in post culture 
cartilage explants 
Rat femoral head cartilage explants (n=8) were treated with I Ong/ml IL-3 and 
10 ng/ml IL-113 for a six day incubation period. Culture media were changed at 24 
hour intervals. GAG concentrations were measured in rat cartilage explant digests 
following the 6 day culture. Analysis of data using a Students t test showed that 
there was no significant difference between the control and and treatment groups. 
GAG concentrations were also measured in culture media collected on days 
and 2. 
5.2.4: Effect of IL-3 and IL-113 on GAG concentration released into the 
culture media by cartilage explants 
Rat femoral head cartilage explants (n=8) were treated with 1 Ong/ml IL-3 and 
I 0 ng/ml IL-113 for a six day incubation period. GAG concentrations were 
measured in the culture media collected on days 1 and 2. Analysis of data using a 
Students t test showed that there was no difference between the control and 
treatment groups. Nitrite concentrations were also measured in culture media 
samples collected at 24 hour intervals during a 6 day culture period. 
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5.2.5: Effect of IL-3 and IL-1(3 on concentration of nitrite produced in the 
culture media by cartilage ex plants during a time course of 6 days 
A time course of nitrite production by rat femoral head cartilage (n=8) in tissue 
culture supernatant was measured during a six day period at 24 hour intervals 
following stimulation with 10 ng/ml of IL-3 and 10 ng/ml of IL-113. Analysis of 
data using a Students t test showed that there was no significant difference was 
observed between control and treatment groups. PGE2 concentrations were also 
quantified in culture media at day I and 2 following combined treatment with IL-3 
and IL-113. 
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5.2.6: Effect of IL-3 on concentration of PGE2 produced by cartilage explants 
Fig. 5.2.6: Effect of IL-3 and IL-1 ~ on PGE2 production 
in rat femoral head cartilage 
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Fig. 5.2.6: Rat femoral head cartilage explants derived from (n=8) were treated 
with l Ong/ml of IL-3 and I 0 ng/ml IL-l f3 for a 48 hour incubation period with a 
change of media at 24 hours. PGE2 concentration was measured in the culture 
media and compared to controls. Analysis of data using a Students t test showed 
that IL-3 and lL-lf3 caused a significant (***P<O.OOI) increase in PGE2 
concentrations in the media on day 2 compared to the same day control group. 
Rat cartilage explants treated with IL-3 and IL-l~ showed a significant (p<O.OO I) 
increase in concentration ofPGEz in the culture media after day 2 compared to the 
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same day control group. Individual treatments with both IL-113 (Fig 3.1.6) and 
IL-3 (Fig 4.2.7) induced production of PGE2 at concentrations of 2.47 ± 0.17 and 
10.6 ± 0.61 ng/ml, respectively. However, the combined treatment of cartilage 
explants with IL-113 and IL-3 induced production of PGE2 at a concentration of 
19.51 ± 4.43 ng/ml. These results showed that, like GM-CSF, combined 
treatments with IL-3 and IL-113 caused increased production of PGE2 compared to 
IL-3 and IL-113 in separate treatments (see Appendix I, Stephan eta/., 1999). 
5.2.7: Discussion of the effects of CSFs and IL-l~ in combined treatments on 
rat femoral head cartilage explants 
Studies by Campbell et a/. (1991 and 1993) revealed that cartilage explants 
produce CSFs in response to IL-113. The present study produced findings that 
identified the combined effects of IL-113 and CSFs on NO production, PGE2 
production and GAG concentrations in rat cartilage explants and release into the 
culture media. 
GAG concentrations in rat cartilage explants were reduced following treatment 
with G-CSF and IL-113 for 6 days compared to controls (Fig 5.1.1 ). This effect was 
comparable the effect of G-CSF on GAGs in cartilage explants (Fig. 4.1.1 ). 
However, in contrast to individual treatments with G-CSF (section 4.1.2) and 
IL-113 (Fig 3.1.3), increased GAG concentrations were observed in detected in the 
culture media after 24 hours compared to same day controls following combined 
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treatment with G-CSF and IL-113. This demonstrated that the combined treatment 
of G-CSF and IL-113 was required to cause release of GAGs from rat cartilage 
explants. 
G-CSF and IL-113 also increased production of nitrite in the culture media at 24 
intervals during a 6 day time course (Fig. 5.1.3). This compared to individual 
treatments with G-CSF (section 4.1.4) and IL-113 (Fig. 3.1.5) that did not cause 
increased nitrite production during a 6 day time course. Elevated nitrite 
concentrations were detected in individual studies using IL-113 (Fig 3.1.4) and 
G-CSF (Fig. 4.1.3) where cartilages were in culture for 6 days with a change of 
media on day 3. Comparison of these results suggest that combined treatment with 
IL-113 and G-CSF may increase production of nitrite by cartilage explants 
compared to individual treatments with IL-113 and G-CSF. The combined 
treatment with G-CSF and IL-113 also increased PGE2 concentrations in the culture 
media (Fig. 5.1.4), however, these were comparable to PGE2 levels produced by 
treatment with IL-113 (Fig. 3.1.6). 
PGE2 concentrations were increased by GM-CSF and IL-3, when combined with 
IL-113. ln separate treatments GM-CSF did not cause cartilage exp1ants to produce 
elevated concentrations of PGE2 in the culture media (section 4.1.9). However, an 
increase in PGE2 production was detected in culture media when combined 
treatments of GM-CSF and IL-113 were administered to cartilage explants (Fig. 
5.1.8). 
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A similar profile was observed when cartilage explants were treated with IL-3 and 
IL-113. Although individual treatment with IL-3 caused elevated PGE2 production 
by cartilage explants (Fig. 4.1.3), the combined effect of LL-113 and IL-3 (Fig 
5.2. 7) was greater than the additive effect of individual treatments with IL-113 and 
IL-3. These finding demonstrated that both IL-3 and GM-CSF have a synergistic 
effect with IL-113 with regard to PGE2 release from rat cartilage explants. This was 
interesting since the same receptor type and intracellular signalling pathways have 
been associated with IL-3 and GM-CSF in other cell systems (Mulhern et a/., 
2000). 
The previous experiments in chapters 3, 4 and 5 have shown the responses of rat 
cartilage explants to CSFs and characterised inflammatory cytokines within an in 
vitro model. It was planned to develop this model to incorporate a fibroblast cell 
type and perform co-culture experiments with IL-113 and CSFs. Swiss 3T3 
fibroblasts were studied as a potential cell type for developing such a co-culture 
model. The effects of IL-113 and CSFs on Swiss 3T3 fibroblast monolayers were 
studied in chapter 6. 
Chapter 6: 
The effects ofiL-lB, TNF-a and CSFs on 
Swiss 3T3 fibroblasts 
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6.10: Introduction 
In chapters 3, 4 & 5, the effects of IL-l~ and CSFs on rat femoral head cartilage 
explants were studied. The rat explant model provided data with respect to 
production of PGE2 and NO, and GAG concentrations in the cartilage explants. 
Cartilage breakdown has been shown to be mediated by inflammatory mediators 
in explant models (Seed et al., 1993; Hanglow et al. , 1995; Stefanovic-Racic et al. , 
1997; Bird et. al. , 1997; Sandy et al., 1999). However, it has also been shown that 
inflammatory process (Honda et al., 2000) and cartilage breakdown (Seed et al. 
1993) are both mediated by other cell types. ln rheumatoid arthritis fibroblast like 
cells located in the synovial pannus tissue have been shown to be involved in the 
pathology of the disease. The present studies have provided findings regarding the 
activity of cartilage within cartilage explants. It was planned to develop the 
cartilage explant model by integrating a fibroblast monolayer culture with 
cartilage explants. These interactions were studied within an in vitro model by 
modifying the rat cartilage explant model (as used in chapters 3, 4, and 5) to co-
culture explants with a monolayer of Swiss 3T3 fibroblasts. 
It was desirable to use a fibroblast cell line that did not release GAGs into the 
culture media. This criteria was crucial to clarify the GAG concentrations detected 
in the culture media were derived from cartilage explants and not released by 
fibroblasts. It was also desirable to use a fibroblast cell line that was responsive to 
IL-l~ · Therefore, prior to comencing co-culture experiments a preliminary study 
was performed using fibroblast monolayers to determine if IL-l~ and CSFs 
influenced their activity with respect to release into the media of GAGs, nitrite and 
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PGE2• It was anticipated that Swiss 3T3 fibroblasts would be responsive to ILl p 
since studies have shown that Swiss 3T3 fibroblasts produce NO and PGE2 in 
response to IL-l P (Burch et a/., 1989). The use of fibroblasts derived from the 
synovium was considered, however, the availability of this cell type prohibited its 
use in this study. 
6.1.1: Swiss 3T3 fibroblasts and GAGs 
A study by Tsiganos et al., (1982) showed that 3T3 cells possessed GAG-like 
moeities on the surface of their extracellular matrix. However, it was not clear if 
these molecules would be released into the culture media and be detectable using 
the DMB GAG binding assay as described by Goldberg and Kolibas, (1990). This 
was explored using cultured fibroblasts monolayers in 24 well plates with a 
control group and individual treatment groups consisting of (n=4) IL-l p, G-CSF, 
GM-CSF, M-CSF and IL-3 at a concentration of I 0 ng/ml. Monolayers were 
cultured from 80 % confluence for 6 days periods with a change of media at 24 
hour intervals. Media samples were collected and GAG concentrations were 
quantified. GAGs were not detected control groups media or in media from 
fibroblasts treated with IL-l P and CSFs. 
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The reponse of Swiss 3T3 fibroblasts to IL-l~ were also measured during a 6 day 
period at 24 hour intervals. Nitrite concentrations were measured throughout the 6 
day period and PGE2 concentrations were measured following days I and 2. The 
results from these studies are illustrated in Figs. 6.1.2 and 6.1.3. 
6.1.2 Effects ofiL-113 on nitrite production by Swiss 3T3 cells 
Fig 6.1.2: Effect of IL-1 J3 on nitrite production by Swiss 
3T3 fibroblasts during a 6 day time course. 
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Fig. 6.1.2: A time course of nitrite production by Swiss 3T3 fibroblasts (n=4) in 
tissue culture supernatant was measured during a six day period at 24 hour 
intervals following treatment with I 0 ng/ml of lL-1 ~· Nitrite was not detected in 
control groups. Analysis of data using a Students t test showed that IL-l~ caused a 
significant (***P<O.OOI) increase in nitrite concentrations in the media at all 
measured time points compared respective control groups. 
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The measurement of nitrite in culture media at 24 intervals from fibroblast 
monolayers revealed that nitrite was not produced in control groups. Conversely, 
treatment with IL-113 increased caused nitrite to be detected at all time points in 
the six day culture. Supplemental experiments showed that fibroblasts cultured in 
media for 3 days produced low concentrations under control conditions. The 
concentrations of PGE2 in media were also quantified at days 1 and 2 following 
treatement offibroblasts with IL-113 (see Fig. 6.1.3). 
6.1.3: Effect ofiL-lJ3 on PGE2 production by Swiss 3T3 fibroblasts 
Fig 6.1.3: Effect of IL-1 J3 on PGE2 production by 
Swiss 3T3 fibroblasts. 
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Fig. 6.1.3: Swiss 3T3 fibroblasts (n=4) were treated with I Ong/ml of IL-l J3 for a 
48 hour incubation period with a change of media at 24 hours. PGE2 
concentrations were measured in the culture media and compared to the control 
group. Analysis of data using a Students t test showed that IL-113 caused a 
significant (***P<O.OOI) increase in PGE2 concentrations in the media on days I 
and 2 compared to the same day control group. 
PGE2 concentrations in the culture media were significantly (p<O.OOI) increased 
on both days I and 2 following treatment with IL-113. Fibroblast monolayers were 
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also treated with TNF-a. to determine its effects on nitrite and PGE2 
concentrations. A dose of I 00 ng/ml of TNFa. was selected to allow comparison 
of results obtained in cartilage explant experiments. The results are illustrated in 
Figs. 6.1.4 - 6.1.5. 
6.1.4: Effect ofTNFa. on nitrite production by Swiss 3T3 fibroblasts 
Fig 6.1.4: Effect of TN F-a. on nitrite production by 
Swiss 313 fibroblasts during a 6 day time course 
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Fig. 6.1.4: A time course of nitrite production by Swiss 3T3 fibroblasts (n=4) in 
tissue culture supernatant was measured during a six day period at 24 hour 
intervals following stimulation with I 00 ng/ml of TNFa. Nitrite was not detected 
in control groups. Analysis of data using a Students t test showed that TNFa 
caused a significant (***P<O.OOI) increase in nitrite concentrations in the media at 
all measured time points compared with respective control groups. 
The measurement of nitrite in fibroblast monolayers revealed that nitrite 
production was not produced in control groups. Treatment with TNF-a resulted in 
an increase of media nitrite levels at all time points in the six day culture. 
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However, concentrations of nitrite produced were lower than concentrations 
detected following treatment with IL-113 (Fig 6.1 .2). The concentrations of PGE2 
in media were also quantified at days 1 and 2 following treatement of fibroblasts 
with I OOng/nl TNFa. The results from this study are illustrated in Fig 6.1.5. 
6.1.5: Effect ofTNF-a on PGE2 production by Swiss 3T3 fibroblasts 
Fig 6.1.5: Effect ofTNF-a on PGE2 production by 
Swiss 3T3 fibroblasts. 
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Fig. 6.1.5: Swiss 3T3 fibroblasts (n=4) were treated with 1 OOng/ml ofTNFa for a 
48 hour incubation period with a change of media at 24 hours. PGE2 
concentrations were measured in the culture media and compared to the control 
group. Analysis of data using a Students t test showed that TNFa caused a 
significant (* * *P<O.OO 1) increase in PGE2 concentrations in the media on days 1 
and 2 compared to the same day control group. 
PGE2 concentrations in the culture media were significantly (p<O.OO 1) increased 
on both days 1 and 2 following treatment with TNF-a. These experiments showed 
that both tL-1 ~ and TN F-a caused Swiss 3T3 fibroblasts to produce elevated 
185 
concentrations of nitrite and PGE2 in vitro compared to controls. Cell viability 
was also assessed after 48 hours of treatments with IL 113 and TN Fa, with a change 
of media at 24 hours to determine if IL-113 and TNFa increased cell death in 
fibroblast monolayers. Cell viabilities were found to be >95 % in controls, IL-113 
and TNF-a treated groups. The effects of CSFs on fibroblast production of nitrite 
and PGE2 were also measured and compared to IL-113 and TNF-a. 
6.1.6: Effect of CSFs on nitrite and PGE2 production by Swiss 3T3 
fibroblasts 
Fibroblast monolayers were treated with CSFs to determine their effects on nitrite 
and PGE2 concentrations in the culture media. Individual doses of 10 ng/ml of 
G-CSF, GM-CSF, M-CSF and IL-3 were selected to provide data that would be 
comparable with data obtained from cartilage explant experiments (see chapter 4). 
Fibroblasts were treated with CSFs during a 6 day culture period and media was 
changed at 24 hour intervals. Nitrite was not detected in media collected from any 
of the CSF treated groups of fibroblast mono layers (n=4) at any time point during 
the 6 day culture period. Basal PGE2 concentrations were produced by both 
control and CSF treated fibroblasts, as in controls in experiments using IL-113 and 
TNFa. However, the CSFs used in these experiments did not significantly change 
concentrations of PGE2 detected in the media compared to respective controls. 
Cell viability was also assessed to determine if CSFs increased cell death in 
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fibroblast monolayers. Cell viabilities were found to be > 95 % in controls and 
CSF treated groups. 
It was observed that the combined treatment of selected CSFs with IL-113 caused 
increased responsiveness of cartilage explants with respect to PGE2 and nitrite 
concentrations produced. G-CSF combined with IL-113 caused increased nitrite 
production and combined treatments with GM-CSF I IL-113 and IL-3 I IL-113 
caused increased production ofPGE2 by rat cartilage explants. 
he response of fibroblast monolayers was determined u lng similar combined 
treatment regime with CS Fs and IL- lj3 . Nitrite was measured du ring a 6 day 
cul ture period with a change of media at 24 hour intervals. PGE2 was quantified at 
day 1 and 2 of culture with a change of media at 24 hours. The results from this 
study are illustrated in sections 6 . 1.7 6 . 1.8 . 
61 7; 1 f~ ct of I -lp and CSF on nitrite production by Swi s 3T3 
Fibr bla t m no lay rs wer tr at d with I -1 p and F to d t rmine their ffe t 
on nitrite concentrations in the c ulture media. A dose of I 0 ng/ml IL- 113 was 
combined with individual doses of 10 ng/ml of G-CSF, GM-CSF, M-CSF and 
rL-3. This provided data that was comparable to results obtained in cartilage 
explant experiments (see chapter 5) and results obtained using LL-113 (Figs. 6.1.2 
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and 6.1.3) and individual treatments of fibroblast monolayers with CSFs (section 
6.1.6). The results of combined treatments are illustrated in Fig. 6.1.7. 
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Fig 6.1.7: Effects of CSFs combined with JL-1[3 on 
nitrite production by Swiss 3T3 fibroblasts 
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Fig. 6.1.7: A time course of nitrite production by Swiss 3T3 fibroblasts (n=4) in 
tissue culture supernatant was measured during a six day period at 24 hour 
intervals following treatment with I 0 ng/ml of IL-l f3 combined with I 0 ng/ml 
doses of Fs. Nitrite wa not detected in control groups. Nitrite production was 
observed in the IL-113 treated monolayers at all time points. Nitrite production in 
combined groups increased from day 1-6 with highest levels of nitrite detected at 
the 6 day period in all combined treatment groups. During days 1 and 2 the 
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concentration of nitrite in all combined IL-113 and CSF treatment groups was 
lower than that in the IL-113 treated group 
[L-113 caused fibroblasts to generate nitrite in the culture media at all time points 
in a 6 day time course. Control fibroblasts did not produce detectable levels of 
nitrite during the time course. Conbined treatments with CSFs and IL-113 resulted 
in generation of nitrite at all time points in the 6 day time course. However, during 
days I and 2 the combined treatment groups of CSFs and IL-113 all produced 
lower concentrations of nitrite than treatment with IL-113. The combined effects of 
IL-113 and CSFs were also studied with respect to PGE2 production by fibroblasts 
during days I and 2 of culture. The results of this study are illustrated in Fig. 6.1.8. 
6.1.7: Effect ofiL-1(3 and CSFs on PGE2 production by Swiss 3T3 fibroblasts 
Fibroblast monolayers were treated with IL-113 and CSFs to determine their effects 
on PGE2 concentrations in the culture media. A dose of I 0 ng/ml IL-113 was 
combined with individual doses of 10 ng/ml of G-CSF, GM-CSF, M-CSF and 
IL-3. These doses were selected to provide comparable data to results obtained in 
cartilage explant experiments (see chapter 5) and results obtained using IL-113 
(Fig 6.1.3) and individual treatments of fibroblast monolayers with CSFs 
(section 6.1.6). The results of combined treatments are illustrated in Fig. 6.1.8. 
Fig. 6.1.8: Effect of CSFs combined with IL-1~ on PGE2 
production by Swiss 3T3 fibroblasts 
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Fig. 6.1.8: Swiss 3T3 fibroblasts (n=4) were treated with 1 Ong/ml of IL-113 and 
10 ng/ml of CSFs for a 48 hour incubation period with a change of media at 24 
hours. PGE2 concentrations were measured in the culture media and compared to 
controls. Control fibroblasts produced basal levels of PGE2 after days 1 and 2. 
Fibroblasts with IL-113 caused an increase in PGE2 concentrations compared to the 
control group on days 1 and 2. Combined treatments of IL-113 and CSFs also 
produced an increase in PGE2 concentrations compared to the control group. 
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During day 2 the concentrations of PGE2 in all combined IL-l J3 and CSF 
treatment groups was lower than that in the IL-l J3 treated group. 
IL-l J3 caused fibroblasts to generate PGE2 in the culture media at both day I and 
2. However, unlike nitrite production, basal levels of PGE2 were detected in 
control media at both day I and 2. A trend was observed in all combined IL-l J3 
and CSF treatment groups that differed from treatment with IL-l J3. Combined 
treatment groups produced lower concentrations of PGE2 than treatment with IL-
l J3 during day 2. Cell viability was assessed to determine if combined treatment 
with IL-l J3 and CSFs increased cell death in fibroblast monolayers. Cell viabilities 
were found to be >95 % in all groups. Media samples from this set of 
experiments were also assayed for GAGs, however, none were detected following 
fibroblast culture. 
6.1.9: Discussion of the effects of CSFs and IL-113 in combined treatments of 
Swiss 3T3 fibroblasts 
The primary objectives of this study were to deterimine if Swiss 3T3 fibroblast 
release GAGs into the culture media and to determine if Swiss 3T3 fibroblasts 
were responsive to IL-l J3 and CSFs. Despite the report by Tsiganos et a/., ( 1982) 
that indicated 3T3 cell possess GAG-like moeities on the surface of their 
extracellular membrane, GAGs were not detected in the culture media in control 
or cytokine treatment conditions (section 6.1.1 ). This result indicated that Swiss 
3T3 fibroblasts were suitable for co-culture with rat cartilage explants since GAGs 
191 
detected in the media would be derived from cartilage explants. It was assumed 
that the presence of rat cartilage explants in the co-culture environment would not 
have caused release of GAGs by fibroblast mono layers. 
Fibroblast monolayers were also studied to determine their responsiveness to 
IL-113 and TN Fa with respect to NO and PGE2 production. Burch et a/., ( 1989) 
showed that fibroblasts produce PGE2 and show elevated expression of COX 
enzymes in response to IL-113. Therefore, it was anticipated that IL-113 would 
caused increased production of nitrite and PGE2 in the culture media. Increased 
concentrations of nitrite (Fig 6.1.2) and PGE2 (Fig 6.1 .3) were indeed detected in 
culture media following treatment with IL-113. PGE2 levels produced by control 
fibroblasts and IL-113 treated fibroblasts were approximately 30 and 350 ng/ml, 
respectively, compared to control and IL-113 treated cartilage explants (Fig. 3.2.1) 
approximately I and 2.5 ng/ml, respectively. 
It was also shown that TN Fa produced a similar increase in levels of nitrite (Fig. 
6.1.3) and PGE2 (Fig. 6.1.4) production by fibroblast monolayers. PGE2 levels 
produced by control fibroblasts and TNF-a treated fibroblasts (approximately 30 
and 400 ng/ml, respectively) were compared to control and TNF-a treated 
cartilage explants (Fig 3.1.6, approximately 1 and 2 ng/ml, respectively). It was 
concluded from these studies that Swiss 3T3 fibroblasts are responsive to IL-113 
and TNFa treatment with regard to nitrite and PGE2 production. 
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These results fulfiled the criteria for use of Swiss 3T3 fibroblasts in a co-culture 
system with rat femoral head cartilages. It was also concluded that Swiss 3T3 
fibroblasts monolayers produce elevated concentrations of PGE2 in control 
conditions and following treatment with IL-l j3 compared to comparative 
concentrations produced by rat cartilage explants in similar conditions. 
Treatment of fibroblast mono layers with CSFs did not cause a significant change 
in nitrite, PGE2 or GAGs detected in the media samples. CSFs were also 
combined with IL-l j3 as in previous studies with cartilage explants (chapter 5). It 
was observed that nitrite concentrations were elevated compared to controls 
following all combined treatment IL-l j3 and CSF. However, it was noted that 
nitrite levels induced by combined treatments were less than nitrite levels induced 
by IL-l j3 on days I and 2 (Fig. 6.1.7). A similar effect was observed when 
measuring concentrations of PGE2. The combined treatments with IL-l j3 and 
CSFs induced PGE2 concentrations that were less than those induced by IL-l j3 on 
day 2 (Fig. 6.1.8). It was concluded that these observations resulted from a non-
specific effect of combined treatments since it was observed in all combination 
treatments. 
This series of experiments confirmed the suitability of using Swiss 3T3 fibroblast 
activity following treatment with fL-1 j3, TNF-a. and CSFs. Swiss 3T3 fibroblasts 
were therefore used in fibroblast-cartilage co-culture experiments, as described in 
chapter 7. 
Chapter 7: 
Effects of IL-l B and CSFs on cartilage 
breakdown in a co-culture model using rat 
femoral head cartilages and Swiss 3T3 
fibroblasts. 
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7.10 Introduction 
lL-113 was shown to increase in PGE2 and NO production by rat femoral head 
explants in a previous study (see chapter 3). However, lL-113 did not cause loss of 
GAGs into the media from the rat cartilage. This contradicted other studies (Seed 
et al., 1993; Hanglow et al., 1995; Stefanovic-Racic et al. 1997; Bird et. al. 1997; 
Sandy et al., 1999; Spirito et al., 1995; Bottomley et. al. , 1997) that showed lL-113 
caused GAG loss from cartilage explants. 
The cartilage explants was therefore integrated with a fibroblasts monolayer to 
produce a fibroblast-cartilage co-culture model. Murine Swiss 3T3 fibroblasts 
were selected for this study since they did not release GAGs into the culture media 
and were responsive to lL-113 treatment with regard to nitrite and PGE2 
production (see chapter 6). The aim of this study was to determine ifthe presence 
of fibroblasts in the model would cause an increase in loss of GAGs from the 
cartilage matrix under control and cytokine treatment conditions. [L-113 was used 
as a treatment co-culture system to determine if GAG loss was induced in rat 
cartilage explants. Since GAGs were not produced in the media of fibroblasts 
alone, loss of GAGs were assumed to be a result of cartilage breakdown in the co-
culture system. Both nitrite and PGE2 were also measured in the co-culture media 
and compared to concentrations of GAGs detected in the culture media during the 
experiments. GAG release and nitrite production were measured during a six day 
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time course to compare with experiments performed using cartilage explants 
(chapters 3, 4 and 5) and fibroblasts (chapter 6). PGE2 concentrations were 
measured at days 1 and 2 to compare with experiments performed using cartilage 
explants (chapters 3, 4 and 5) and fibroblasts (chapter 6). Fibroblast viabilities 
were also assessed following 6 day co-culture experiments to determine if cell 
death occured in fibroblast mono layers. The results of IL-l~ treatment in the 
co-culture system are illustrated in Figs. 7.1.1-7.1.3. 
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7.1.1: Effect of IL-113 on GAG release from cartilage explants co-cultured 
with Swiss 3T3 fibroblasts 
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Fig. 7.1.1: Effect of IL-113 on GAG release into culture 
media from rat femoral head cartilage co-cultured with 
Swiss 3T3 Fibroblasts during a six day time course. 
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Fig. 7.1.1: A time course of GAG release by rat femoral head cartilage explants 
co-cultured with fibroblasts (n=6) was measured in tissue culture supernatants 
during a six day period at 24 hour intervals following treatment with I 0 ng/ml of 
fL-113 . Analysis of data using a Students t test showed that IL-113 produced a 
significant (*= P<0.05) increase GAG concentrations in the culture media 
compared to the control group during days I, 2, 4 and 5. 
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GAG concentrations in culture media from co-culture controls showed a trend of 
being elevated compared to GAG concentrations in control groups within rat 
cartilage explant experiments (Fig 3.1.3). This demonstrated that the presence of 
fibroblasts caused increased loss of GAGs from cartilage explants. The co-cultures 
were treated with IL-113 at a concentration of I Ong/ml to determine if GAG loss 
would be elevated compared to control co-culture cultures (see Fig 7 .I. I). 
Co-culture of cartilage explants with fibroblasts during a six day time course 
treated with IL-113 produced a significant (p<0.05) increase in GAG 
concentrations in media compared to controls on days l, 2, 5 and 6. It was 
observed that GAG concentrations released from explants in both control and IL-
113 treated groups decreased on days 3 & 4, then increased at days 5 and 6. This 
trend was compared with nitrite levels generated in the media during a six day 
time period. These results were illustrated in Fig 7 .1.2. 
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7.1.2: Effect of IL-1J3 on nitrite produced by a co-culture of rat cartilage 
explants with Swiss 3T3 fibroblasts 
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Fig. 7.1.2: Effect of IL-1J3 on nitrite production by a co-
culture of rat cartilage explants with Swiss 3T3 
fibroblasts 
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Fig. 7.1.2: A time course of nitrite production by rat femoral head cartilage 
explants co-cultured with Swiss 3T3 fibroblasts was measured in tissue culture 
supernatant during a six day period at 24 hour intervals following stimulation with 
10 ng/ml of IL-l f3 . Analysis of data using a Students t test showed that nitrite 
concentrations in the culture media were significantly (p<O.OO 1) higher in the 
IL-l J3 treated group compared to the same time control group at all time points. 
Co-culture of cartilage explants with fibroblasts during a six day time course 
produced a significant (***P<O.OOI) increase in nitrite concentrations in media 
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compared to controls at all time points. It was observed that nitrite concentrations 
decreased at days 3 and 4 in IL-II3 treated groups then increased on days 5 and 6. 
This resembled the trend observed in the GAG loss profile from the IL-113 treated 
co-cultures during the 6 day time course. Conversely, nitrite concentrations in 
media from the control group decreased from days I and 2 and remained low 
throughout days 3, 4, 5, and 6. 
PGE2 was also measured in culture media from co-cultures during days I and 2. 
This provided data to compare with GAGs and nitrite production during the days I 
and 2 of the 6 day time course experiments. The results from this study are 
illustrated in Fig. 7.1.3 . 
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7.13: Effect of IL-113 on concentration of PGE2 produced by a co-culture of 
rat cartilage explants with Swiss 3T3 fibroblasts 
Fig. 7 .1.3: Effect of IL-1 p on PGE2 production by a co-
culture of rat cartilage explants with Swiss 3T3 
fibroblasts 
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Fig. 7.1.3: Rat femoral head cartilage explants (n=8) co-cultured with Swiss 3T3 
fibroblasts were treated with I Ong/ml of LL-1 ~ for a 2 day incubation period with 
a change of media at 24 hours. PG E2 concentrations were measured in the culture 
media and compared to the control group. Analysis of data using a Students t test 
showed that concentrations of PGE2 in the culture media from the IL-113 treated 
group were significantly (p<O.OO 1) elevated compared to same time controls at 
days I and 2. 
fL-113 treatment resulted in a significant (***P<O.OOJ) increase of PGE2 
production after days I and 2. The concentration of PGE2 detected in the 
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co-culture system following treatment with IL-113 (Fig. 7 .1.3) was comparable to 
the sum of the concentrations of PGE2 produced by cartilages (Fig. 3.1.6) and 
fibroblasts (Fig. 6.1.3). The effects of the CSFs on Swiss 3T3 fibroblasts 
co-cultured with cartilage explants were also studied with respect to GAGs, nitrite 
and PGE2 in the culture media and compared to results obtained following 
treatment of cultures with Il.,-113. These results were illustrated in Figs 7.1.4-7 .1.6. 
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7.1.4: Effects of CSFs on GAG release from cartilage explants co-cultured 
with Swiss 3T3 fibroblasts 
Fig. 7.1.4: Effect of CSFs on GAG release into culture 
media from rat femoral head cartilage co-cultured with 
Swiss 3T3 Fibroblasts during a six day time course. 
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Fig. 7.1.4: A time course of GAG release by rat femoral head cartilage explants 
co-cultured with fibroblasts (n=6) was measured in tissue culture supernatants 
during a six day period at 24 hour intervals following individuall treatments with 
10 ng/ml ofG-CSF, GM-CSF, M-CSF and IL-3 . Analysis of data using a Students 
t test showed that concentrations of GAGs in the culture media from the IL-3 
treated group were significantly (p<0.05) elevated compared to same time controls 
on days 1 and 4. 
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IL-3 produce a significant (p<0.05) increase in GAG release from cartilage 
explants on days 1 and 4. This differed from treatment with IL-3 that did not 
increase GAG release from cartilage explants (section 4.2.4). However, in the 
previous study cartilage explants produced increased levels of PGE2 in media 
when treated with fL-3 (Fig. 4.2.7) . Like IL-3, GM-CSF appeared to induce an 
increase in GAG loss from cartilage explants at day 4, however a students t test 
revealed that the difference observed was not significant due to the large degree 
variability in this group. Nitrite concentrations were also measured in media and 
compared with GAG concentrations in co-culture experiments with CSFs. Result 
from this study are illustrated in Fig. 7.1.5. 
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7.1.5: Effect of CSFs on nitrite produced by a co-culture of rat cartilage 
explants with Swiss 3T3 fibroblasts 
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Fig. 7.1.5: Effect of CSFs on nitrite production by a co-
culture of rat cartilage explants with Swiss 3T3 
fibroblasts 
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Fig. 7.1.5: A time course of nitrite production by rat femoral head cartilage 
explants co-cultured with Swiss 3T3 fibroblasts was measured in tissue culture 
supernatant was measured during a six day period at 24 hour intervals following 
stimulation with 10 ng/ml ofG-CSF, GM-CSF, M-CSF and IL-3 . Analysis of data 
using a Students t test showed that concentrations of nitrite in the culture media 
were not changed by treatment with CSFs compared to the control group. 
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Treatment with CSFs did not cause significant changes of nitrite concentrations in 
media compared to controls at 24 hour intervals during a 6 day time course. This 
compared with CSF treatments in cartilage experiments (chapter 4) and in 
fibroblast experiments (chapter 6) in which no significant differences were 
observed from controls at 24 hour intervals during a 6 day time course. 
PGE2 concentrations were also measured following treatment with CSFs at days I 
and 2 to compare with levels of nitrite and GAGs released into the media at days I 
and 2. Comparison was also made with concentrations of PGE2 produced 
following treatment with CSFs by cartilage explants (chapter 4) and fibroblasts 
(chapter 7). Results from this study were illustrated in Fig. 7.1.6. 
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7.1.6: Effect of CSFs on concentration of PGE2 produced by a co-culture of 
rat cartilage explants with Swiss 3T3 fibroblasts 
Fig. 7.1.6: Effect of CSFs on PGE2 production by a co-
culture of rat cartilage explants with Swiss 3T3 
fibroblasts 
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Fig. 7.1.6: Rat femoral head cartilage explants (n=8) co-cultured with Swiss 3T3 
fibroblasts were treated with individual doses of 1 Ong/ml of G-CSF, GM-CSF, M-
CSF and IL-3 for a 2 day incubation with a change of media at 24 hours. PGE2 
concentrations were measured in the culture media and compared to the control 
group. Analysis of data using a Students t test showed that concentrations of PGE2 
in the culture media were significantly (p<0.05) increased by G-CSF, GM-CSF 
and IL-3 on days I and 2. 
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G-CSF, GM-CSF and IL-3 all caused a significant increase (P<0.05) in PGE2 
production in the co-culture system compared to controls. This compared to 
previous experiments with fibroblasts where G-CSF, GM-CSF, M-CSF and IL-3 
did not have an effect on PGE2 production (section 6.1.6) and previous cartilage 
experiments where G-CSF (Fig. 4.1.5) and IL-3 (Fig. 4.2. 7) caused a significant 
increase in production of PGE2. Fibroblast viabilities were also assessed after a 6 
day culture with CSFs and found to be in >95% in all groups. 
The combined effects of IL-113 and CSFs were studied during in experiments 
performed using cartilage explants (see chapter 5) and fibroblasts (see chapter 6). 
The combined effects of CSFs with IL-113 were also studied using the co-culture 
system. The results of using IL-113 in the co-culture system showed that 
IL-113 caused an increase in GAG loss from the cartilage explants (Fig. 7 .1.1 ). A 
combined study using IL-113 and CSF was performed with IL-113 at 1 Ong/ml and 
individual concentrations ofG-CSF, GM-CSF, M-CSF and IL-3 at a concentration 
of l 0 ng/ml. GAG release and nitrite production were measured during a 6 day 
time course and PGE2 concentrations were measured at days 1 and 2. Fibroblast 
viabilities were also assessed following co-culture experiments. The results from 
these studies were illustrated in Figs 7.1.7-7.1.9. 
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7.1.7: Effects of IL-l~ and CSFs on GAG release from cartilage explants co-
cultured with Swiss 3T3 fibroblasts 
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Fig. 7.1.7: Effect of IL-1~ and CSFs on GAG release into 
culture media from rat femoral head cartilage co-
cultured with Swiss 3T3 fibroblasts during a six day 
time course. 
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Fig. 7.17: A time course of GAG release by rat femoral head cartilage explants 
co-cultured with fibroblasts (n=6) was measured in tissue culture media during a 
six day period at 24 hour intervals following treatment with 1 Onglml of IL-l~ 
combined with individual treatments with 10 nglml of G-CSF, GM-CSF, M-CSF 
and IL-3. Combined treatments using IL-l~ and CSFs resulted in a significant 
(*P<0.05) increase in GAG loss from cartilage explants at days I and 4. 
Significant (*P<0.05) increases in GAGs loss were also observed on days 3 and 4 
following treatment with GM-CSF and IL-l~. and on day 4 following treatment 
with IL-l~ and lL-3. 
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Combined treatments of CSFs and [L-113 resulted in a trend of increased GAG 
concentrations detected in the media compared to respective controls. However, 
significant increases (*P<0.05) in all combined treatments were only detected on 
days I and 6. Combined treatments with IL-113 and GM-CSF, and IL-113 and IL-3 , 
caused significant increases in GAG release from the cartilage explants on days 3 
and 4, and day 3, respectively. The combined treatment regime with IL-113 and 
CSFs (Fig. 7 .I. 7) produced results that were comparable to treatment using IL-113 
in the co-culture system on days I and 6 (Fig 7 .1.1 ). The concentrations of nitrite 
produced by combined treatment with IL-113 and CSFs were also measured during 
a 6 day time course. The results from this study were illustrated in Fig. 7 .1 .8. 
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7.1.8: Effect of IL-113 and CSFs on nitrite produced by a co-culture of rat 
cartilage explants with Swiss 3T3 fibroblasts 
-::!: 
.5 
1: 1: cu 0 Q) ; E cu 
... Q) 
-1:..1: Q)-
CJ .... 
1: 0 
ow 
ucn 
~+I 
'i: 
~ 
1: 
Fig. 7 .1.8: Effect of IL-113 and CSFs on nitrite produced 
by a co-culture of rat cartilage explants with Swiss 3T3 
fibroblasts 
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Fig. 7.1.8: A time course of nitrite production by rat femoral head cartilage 
explants co-cultured with Swiss 3T3 fibroblasts was measured in tissue culture 
supernatant was measured during a six day period at 24 hour intervals following 
treatment with 10 ng/ml of IL-113 combined with G-CSF, GM-CSF, M-CSF and 
LL-3 . Analysis of data using a Students t test showed that nitrite concentrations in 
the culture media were significantly (p<O.OO 1) elevated in all combined IL-113 and 
CSF treated groups compared to respective time control groups at all time points. 
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Combined treatment with IL-113 amd CSFs resulted in elevated concentrations of 
nitrite in the media of all groups compared to controls. In all treatment groups 
nitrite concentrations were initially elevated compared controls followed by a 
decrease where lowest levels were detected at day 3. Levels of nitrite then 
increased during the time course reaching elevated levels on day 6 that were 
comparable to day 1. This trend was not observed in the control group during the 
time course. Concentrations of PGE2 were also measured on days 1 and 2 
following combined treatments with CSFs. These results were illustrated in 7.1.9. 
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7.1.9: Effect ofiL-113 and CSFs on concentration ofPGE2 produced by a co-
culture of rat cartilage explants with Swiss 3T3 fibroblasts 
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Fig. 7.19: Effect of IL-113 and G-CSF on PGE2 
produced by a co-culture of rat cartilage explants 
with Swiss 3T3 fibroblasts 
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Fig. 7.1.9: Rat femoral head cartilage explants (n=6) co-cultured with Swiss 3T3 
fibroblasts were treated with I Onglml of IL-l f3 combined individual treatments 
with G-CSF, GM-CSF, M-CSF and IL-3 for a 2 day incubation period with a 
change of media at 48 hours. PGE2 concentration was measured in the culture 
media and compared to controls. Analysis of data using a Students t test showed 
that PGE2 concentrations in the culture media were significantly (p<O.OOl) 
elevated in all combined IL-l f3 and CSF treated groups compared to respective 
time control groups at all time points. 
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Concentrations of PGE2 produced by combined treatments of IL-l~ and CSFs in 
the co-culture system were elevated in all treatment groups at days I and 2 
compared to controls (Fig. 7 .1.9). The concentrations of PGE2 produced in the co-
culture system following combined treatment with IL-l~ and CSF were 
comparable in magnitude to concentrations of PGE2 produced by treatment with 
IL-l~ (Fig. 7 .1.3 ). 
7.2.0: Discussion of the effects of CSFs and IL-lf3 in the co-culture system 
using Swiss 3T3 fibroblasts and rat cartilage explants 
Uisng a co-culture system incorporating murine Swiss 3T3 fibroblasts with rat 
femoral head cartilages IL-l~ caused a significant increase in GAG release into 
media (Fig. 7.1.1), and production of nitrite (Fig. 7.1.2) and PGE2 (Fig. 7.1.3). 
This compared to results using rat cartilage cartilage explants where IL-l~· 
However, in experiments with rat cartilage explants, IL-l~ caused an increase in 
production of nitrite (Fig. 3.1.4) and PGE2 (Fig. 3.1.6). Previous experiments with 
swiss 3T3 fibroblasts also demonstrated that IL-l~ increased production of nitrite 
(Fig 6.1.2) and PGE2 (Fig. 6.1.3). It was concluded that the presence of fibroblasts 
in the system served to augment IL-l~ induced loss of GAGs from rat cartilage 
explants in this in vitro model. 
Loss of GAGs in the co-culture system occured when concentrations of nitrite 
(Fig. 7.1.2) and PGE2 (Fig 7.1.3) were elevated in the culture media. Nitrite 
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concentrations in the co-culture system (Fig 7.1.2) were elevated compared to 
nitrite concentrations detected in cartilage explant cultures, following treatment 
with IL-l~ (Fig. 3.1.5). ln the co-culture system the maximum concentration of 
nitrite detected was 14.6 +/- 1.5 J.lM on day 2 (Fig 7 .1.2), compared to previous 
experiments with rat cartilage explants where the maximum concentration of 
nitrite detected was 7.3 +/- 1.0 J.lM, also on day 2 (Fig 3.1.5). Fibroblasts produced 
13.2 +I- 2.3 J.lM nitrite following treatment with IL-l~ on day 2 (Fig. 6.1.2). It was 
concluded that cartilage explants in the co-culture system were exposed to 
elevated levels of nitrite (Fig 7.1.2) compared to previous experiments using 
cartilage explants treated with lL-1 ~during a six day time course (Fig. 3.1.5). 
PGE2 concentrations in the co-culture system (Fig 7.1.3) were elevated compared 
to PGE2 concentrations detected in cartilage explant cultures, following treatment 
with IL-l~ (Fig. 3.1.6). In the co-culture system the maximum concentration of 
PGE2 detected was 378 +/- 50 ng/ml on day l (Fig 7.1.3), compared to previous 
experiments with rat cartilage explants where the maximum concentration of 
PGE2 detected was 2.47 +/- 0.17 ng/ml, on day 1 (Fig 3.1.5). Fibroblasts produced 
359 +/- 22 ng/ml PGE2 following treatment with IL-l~ on day 2 (Fig. 6.1.3). It 
was concluded that cartilage explants in the co-culture system were exposed to 
elevated levels of PGE2 (Fig 7.1.3) compared to previous experiments using 
cartilage explants treated with lL-1 ~ during a six day time course (Fig. 3.1.6). It 
was also concluded that the majority of PGE2 produced in the co-culture system 
was derived from fibroblasts. 
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CSFs were also used in the co-culture system to determine their effects on GAG 
loss from cartilage explants and effects on nitrite and PGE2 production. IL-3 
produced increased GAG loss at days 1 and 4 from cartilage explants in the 
co-culture system during a 6 day time course (Fig 7.1.4). This compared to 
previous cartilage explant experiments where IL-3 did not change GAG release 
into the media (Fig 4.2.5). 
G-CSF, GM-CSF, M-CSF and IL-3 did not affect production of nitrite in the co-
culture system (Fig 7 .1.5) during a six day time course. This compared to previous 
experiments with cartilage (sections 4.1.4, 4.1.8, 4.2.2 and 4.2.6) where no change 
in nitrite production was observed following treatment with G-CSF, GM-CSF, 
M-CSF and IL-3, respectively. In previous experiments using fibroblasts (section 
6.1.6) the aforementioned CSFs did not affect nitrite concentrations during a six 
day time course. Conversely, G-CSF, GM-CSF and IL-3 caused an increase in 
production of PGE2 in the co-culture system. In contast, M-CSF did not affect the 
production of PGE2 in the co-culture system. This compared to previous 
experiments with fibroblasts where G-CSF, GM-CSF, M-CSF and IL-3 did not 
affect production of PGE2 (section 6.1.6). However, previous experiments using 
cartilage explants demonstrated that treatments with G-CSF (Fig. 4.1.5) and IL-3 
(Fig 4.2.7) caused an increase in PGE2 production, yet GM-CSF did not affect 
PGE2 levels. The elevated concentration of PGE2 produced by G-CSF (Fig. 4.15) 
and IL-3 (Fig 4.2. 7) in cartilage experiments were 4.16 +/- 1.10 and 10.60 +/-
0.31 ng/ml, respectively. This compared to elevated PGE2 concentrations 
produced by G-CSF, IL-3 and GM-CSF in the co-culture system that were 215 +/-
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76, 256 +/- 83 and 177 +/- 21 ng/ml respectively. It was concluded from these 
results that the presence of fibroblasts in the co-culture system serves to augment 
the production PGE2 in the presence ofG-CSF, GM-CSF and IL-3. 
Combined treatments using CSFs and IL-l p were used, as in previous 
experiments using fibroblasts (chapter 6) and cartilage explants (chapter 5) to 
determine the effects on GAGs, nitrite and PGE2 in the co-culture system. 
Combined treatments with IL-l P and all CSFs caused increased production of 
nitrite (Fig 7.1.8) and PGE2 (Fig. 7.1.9) in the culture media. However, these 
effects were comparable increases in nitrite (Fig. 7.1.2) and PGE2 (Fig. 7.1.3) 
production observed following treatment with IL-l p in the co-culture system. 
Il-l p was shown regulate the loss of GAGs in the fibroblast-cartilage co-culture 
system and to increase production of nitrite and PGE2 in this system. A study was 
performed using IL-l p as a positive control and attempting to elucidate the 
involvement of intracellular signal transduction pathways in the Swiss 3T3 
fibroblasts and rat cartilage explants leading to production and release of nitrite 
into the culture media studying cartilage and fibroblasts in separate experiments. 
These results were illustrated in chapter 8. 
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Chapter 8: 
Intracellular Signaling pathways and release 
of NO: Effects of MAP kinase inhibitors in 
Swiss 3T3 fibroblasts and rat femoral head 
cartilage. 
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8.1.0 Introduction 
Previous studies have shown that IL-l~ produces elevated concentrations of NO 
and PGE2 in both rat cartilage explants (chapter 3) and Swiss 3T3 fibroblasts 
(chapter 6). Elevated concentrations ofNO and PGE2 in a co-culture system have 
correlated with elevated release of GAGs from the cartilage matrix (chapter 7) in a 
fibroblast-cartilage co-culture system. However, the intracellular events from 
lL-1 ~ binding to the cell to release of NO in rat chondrocytes and Swiss 3T3 
fibroblasts have not been fully characterised. It has been shown that intracellular 
signaling pathways leading to production of NO are activated by a number of 
factors such as cytokines, endotoxins and stress. Nitric oxide was the focus ofthis 
study since it has been implicated with GAG breakdown (Hassan et a/., 1998), 
activation of metalloproteinases (Murrell et a/., 1995), induction of COX activity 
(Honda et al., 2000) and induction of PGE2 production (Blanco and Lotz, 1995). It 
has been shown in studies by (Badger et a/., 1998; Ridley et a/., 1998) that IL-l 
induced iNOS expression and COX-2 mRNA were downregulated respectively, 
when the p38 MAP kinase pathway was specifically inhibited. 
Two MAP kinase pathways, p38 MAP kinase and ERK l/2 were targetted using 
highly specific inhibitors to determine whether production of NO induced by 
lL-l ~ in fibroblasts and rat cartilage explants could be suppressed. These MAP 
kinases were selected on the basis that both p38 mitogen activated protein (MAP) 
kinase and extracellular signal related kinase (ERK) can act as intermediates in 
cytokine and growth factor signalling within mammalian cells (Cohen, 1997) 
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(Wang et al., 1998). A study by Alessi et al. (1995) showed that PD 98059 was a 
specific inhibitor of ERK 1 and ERK 2 ligands within Swiss 3T3 cells and human 
fibroblasts. A study by Badger et a/. ( 1998) using bovine chondrocyte cultures and 
bovine explant cultures demonstrated that SB 203580 inhibits p38 MAP kinase, 
iNOS expression and production of nitric oxide. Both SB 203580 and PD 98059 
were therefore used to determine if they inhibited nitrite induced by rat cartilage 
explants and Swiss 3T3 Fibroblasts. 
SB 203580 was used at a concentration of 2)..lM. The IC50 value of nitrite 
inhibition following treatment with IL-l~ was characterised by Badger et al., 
(1998) using bovine chondrocytes was 0.6 - 1.0 )..lM. In the present study, SB 
203580 was used at a concentration of 2)..lM because it has been shown that SB 
203580 remains a specific inhibitor of p38 MAP kinase affecting activity of ERK 
at concentrations lower than I 0~-tM. PD 98059 was used at a concentration of 
50)..lM. This concentration was used since Alessi eta/. (1995) showed that the IC50 
for inhibition of ERK 1 I ERK 2 at this concentration was 50)..lM. Fibroblast 
viability was measured following experiments using SB 203580 and PO 98059 to 
confirm that these inhibitor were not causing cell death at these concentrations. 
IL-l~ was used at 10 ng/ml as a positive control for nitrite production in both 
cartilage and fibroblast experiments. A maximum final concentration of 0.5% v/v 
DMSO was used as a vehicle for these inhibitors. DMSO controls were run to 
ensure that toxicity was not induced by the vehicle and DMSO-IL-1 ~ controls 
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were run to ensure that DMSO did not reduce nitrite concentrations in the media. 
The results ofthese experiments are shown in Figs 8.1.1 & 8.1.2. 
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Fig. 8.1.1: The effect of SB 203580 and PD 98059 on nitrite production 
induced by IL-1~ in Swiss 3T3 fibroblasts. 
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Fig: 8.1.1: Effect of SB 203580 and PD 98059 inhibitors 
on IL-1 ~ induction of nitric oxide in Swiss 3T3 
fibroblasts 
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8.1.1: Swiss 3T3 Fibroblasts were treated with l Ong/ml IL-l~. 21-.l.M SB 203580 
(SB), 50J..1.M PD 98059 (PD), IL-l ~+SB, JL-li3+PD and IL-II3+SB+PD for a 2 
day period with a change of media following the initial 24 hours. Analysis of data 
using a Students t test showed that nitrite concentrations in the culture media were 
significantly (* P<0.05) elevated in IL-113 and IL-113 + PD treated groups points 
on day I and significantly elevated (*P<O.OO I) by IL-113 on day 2, compared to 
respective control groups. The effect of IL-113 on nitrite was suppressed by SB on 
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days I and both SB and PO on day 2. The combined treatment with SB + PO also 
suppressed nitrite production on days I and 2. 
LL-113 caused an increase in nitrite production by fibroblasts as in previous 
experiments (Fig 6.1.2). SB 203580 and PO 98059 both caused a reduction in the 
effect of IL-113 on nitrite production by fibroblasts. SB 203580 inhibited the 
release of nitrite by IL-113 on days I & 2. PO 98059 also reduced nitrite levels on 
day 2, but had no effect on nitrite concentrations during the initial 24 hours of 
culture. When the two inhibitors were combined with IL-113, the release of IL-113 
on nitrite production was inhibited. SB 203580 and PO 98059 had no obvious 
effect on fibroblasts when administered without IL-113. Cell viability was 
measured in all groups and was shown to be >95%. These results demonstrated 
that both SB 203580 and PO 98059 inhibited production of nitrite in culture media 
by Swiss 3T3 fibroblasts monolayers. The response of cartilage explants and 
nitrite release were also studied using IL-113 as a positive control in combination 
with SB 203580 and PO 98059. The results of this study were illustrated in Fig. 
8.1.2. 
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8.1.2: The effect of SB 203580 and PD 98059 on nitrite production induced by 
IL-113 in rat cartilage explants. 
Fig 8.1.2: Effect of SB 203580 and PO 98059 on IL-1 J3 
induction of nitric oxide in rat cartilage explants 
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Graph 8.1.2: Rat cartilage explants were treated with I Ong/ml IL-113, 2J.!M SB 
203580 (SB), 50J.!M PD 98059 (PD), IL-lj3+SB, IL-lj3+PD and IL-lj3+SB+PD for 
a 2 day period with a change of media following the initial 24 hours. Analysis of 
data using a Students t test showed that nitrite concentrations in the culture media 
were significantly (*P<0.05) elevated in IL-Ij3,lL-lj3 + PO and IL-113 + SB 
treated groups points on days I and 2. The effect of lL-lj3 on nitrite production 
was ameliorated by SB + PO on days 1 and 2. SB, PD and SB + PD did not 
change nitrite concentrations compared to same time controls. 
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Results shown in Fig. 8.1.2 show the effects of SB 203580 and PO 98059 when 
combined with IL-l~· In this study IL-l~ caused increased production of nitrite by 
rat cartilage explants. However, unlike the comparative study using fibroblasts 
(Fig. 8.1.1 ), concentrations of nitrite produced by cartilage explants were not 
significantly reduced by separate treatments with SB 203580 and PO 98059 when 
combined with IL-l~. However, use ofSB 203580 +PO 98059 with IL-l~ caused 
a reduction in levels of nitrite released reduced compared to IL-l~ treated 
cartilages (Fig 8.1.2). Control cartilages produced a basal concentration of nitrite 
as in previous experiments (chapters 3, 4 and 5). Treatment of control cartilage 
explants with SB, PO and SB + PO did not affect basal levels of nitrite production 
(Fig 8.1.2). 
8.1.3: Discussion 
The p38 MAP kinase (Cohen, 1997) and ERK 1/2 (Wang et al., 1998) signalling 
pathways have been implicated in the signalling pathway of cytokines. Specific 
inhibitors SB 203580 and PO 98059 were used to specifically target these 
respective intermediates to determine if nitrite production induced by IL-l~ would 
be suppressed. A study using Swiss 3T3 fibroblasts (Fig. 8.1.1) demonstrated that 
SB 203580 and PO 98059 inhibited production of nitrite induced by IL-l~. This 
compared with a study by Oa Silva et al., (1997) using murine astrocytes that 
showed that blockade of p38 MAP kinase inhibited iNOS expression induced by 
IL-l~, however, PO 98059 had no effect on iN OS expression induced by IL-l~· 
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The different cell types, murine astrocytes and 3T3 fibroblasts, may account for 
the differences observed with regard to PD 98059 inhibition of iNOS expression 
in the respective studies. It was concluded from the results of the present study 
that both p38 MAP kinase and ERK 1/2 pathways are involved in transduction of 
the intracellular signal induced by lL-113 that results in nitrite production by Swiss 
3T3 fibroblasts . 
However, in a comparative study using rat cartilage explants SB 203580 and PD 
98059 failed to suppress the effects of IL-113 on nitrite production (Fig 8.1.2) in rat 
cartilage explants. However, when SB 203580 and PD 98059 were combined the 
effect of nitrite production by IL-113 was reduced. These findings are not in 
accordance with those in a study by Badger eta/. , (1998) where SB 203580 alone, 
at comparative concentrations to those used within the present study, inhibited 
nitrite produced by bovine cartilage explants. Conversely, a study by Caivano 
(1998) showed that SB 203580 did not affect induction of iNOS in macrophages. 
The discrepancy between results obtained in the present study compared to the 
study by Badger eta/. , (1998) and Caivano, (1998) may be due to the differences 
between different cell and species types. Results obtained by Badger eta/., (1998) 
supported data obtained in this study showing that PD 90859 and SB 203580 do 
not influence constitutive production of nitrite by cartilage explants. It was 
concluded that both SB 203580 and PD 98059 were involved in the inducible 
nitrite production pathway in present study and therefore p38 MAP kinase and 
ERK 1 I 2 are involved in transduction of the intracellular signal, induced by lL-
113, leading to production of nitrite by rat cartilage explants. It was speculated that 
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the Jack of effect of SB 203580 alone on cartilage explants may have been caused 
by restriction of SB 203580 interaction with chondrocytes by the rat cartilage 
matrix. 
It was planned to conduct experiments with these inhibitors to measure their effect 
on PGE2 production by fibroblasts and cartilage explants and their effect in the 
co-culture system where fibroblasts and cartilage produced significant release of 
nitrite, PGE2 and GAGs from the cartilage matrix following treatment with 
IL-lj3. However, it was not possible to perform this study due to limited rat 
cartilage availability. 
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Chapter 9: 
General Discusssion 
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9.1.0: Cartilage explants used as a model of cartilage breakdown 
Cartilage explants have been previously utilised to model the breakdown of 
articular cartilage in vitro. The preliminary study in this research involved a study 
of GAG loss from cartilage explant in an in vitro system (section 3.1.0). The aim 
of this study was to select a cartilage explant type that would be suitable for 
investigating the process of cartilage breakdown by measurement of 
glycosaminoglycans (GAGs), production of nitric oxide (NO) and prostaglandinE2 
(PGE2) in response to cytokines. GAGs have been shown to be essential 
components of cartilage matrix and are lost from the extracellular matrix as a 
consequence of cartilage breakdown, (Billington et al., 1998; Bottomley et al. , 
1997; Wertheimer et al., 1995). NO (Evans and Stefanovicic, 1996) and PGE2 
(Prete et al., 1997) are both markers of inflammation that may serve to exacerbate 
the loss of GAGs from the cartilage matrix. 
The criteria for selection of a cartilage type was based upon the activity of 
cartilage under control conditions with respect to levels of GAGs in cartilage 
explants and culture media during a 6 day time course. It was considered 
important that cartilage components were not lost under control conditions in an in 
vitro culture environment. This characteristic was paramount to ensure that 
cartilage breakdown could be measured as a consequence of cytokine treatment 
and distinguished from cartilage breakdown caused as a consequence of the in 
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vitro conditions. Availability of cartilage samples and uniformity of cartilage 
explant samples were also considered when this pilot study was undertaken. 
Measurement of GAGs in media and explants following explant culture revealed 
that both human and rat cartilage displayed suitable characterisitics for use an in 
vitro study. Rat and human cartilage explants lost 20% and 27%, respectively, of 
GAG content during culture over a 6 day period. Conversely, porcine nasal and 
articular cartilage explants showed high percentage GAG losses into the culture 
media during the 6 day incubation. Porcine nasal and porcine articular cartilage 
lost 46% and 43% of total GAG content as a consequence of explant culture 
during 6 days. Although human tissue samples produced a suitable profile with 
respect to GAG Joss under control conditions, the availability of human cartilage 
explants was limited. The quantity of human femoral head cartilage was variable 
on human femoral heads obtained from hip fracture patients. The process of 
extraction of human cartilage also led to regional variability in cartilage samples 
since articular cartilage is composed of different zones with varying physical 
properties (section 1.1 .5). 
Unlike human cartilage explants, rat cartilage explants consisted of entire cartilage 
femoral heads comprising all of the zonal regions described. It was therefore 
considered that entire rat cartilage explants would provide more reliable data in a 
model of cartilage breakdown than using explants derived from different regions 
ofhuman femoral head samples. 
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Further studies demonstrated that rat femoral head cartilages were responsive to 
inflammatory mediators such as interleukin-1 f3. Treatment of rat cartilages with 
10 ng/ml of IL-l f3 resulted in generation of NO and PGE2• The response of rat 
cartilage explants to IL-l f3 produced a standard for comparison in successive 
studies using colony stimulating factors (CSFs). 
It was surprising that neither IL-l f3, TNF-a or LPS induced an increase in loss of 
GAGs from the explants during explant culture. In other studies IL-l f3 (Seed eta/. , 
1993; Hanglow et al. , 1995; Spirito et al. , 1995; Stefanovic-Racic et a/. , 1997) 
TNF-a (Homandberg et al., 1998; Stichtenoth and Frolich, 1998) and LPS 
(Morales et al., 1984) have all been shown to increase cartilage breakdown. 
Indeed, the use of IL-l f3 and TNF-a antagonists have been implicated as a 
therapeutic aid to reduce the symptoms associated with arthritic disease (Moreland 
et al. , 1997). Despite the effects of IL-l f3 on NO and PGE2 production, the rat 
cartilage explants failed to show increased loss of GAGs in this system following 
treatment with IL-l f3. The reason for this may have been due to the fact that rat 
tissue does not produce MMP-1 , as subsequently indicated in a study by 
(Greenwald eta/., 1998). It was speculated that the ability of cytokines to interact 
with chondrocytes may have been hindered by the cartilage matrix in the explant 
experiments performed in this study. It was also noted that the source of 
recombinant cytokines was different from that of cytokines used in other cited 
studies. These factors may have influenced the ability of rat chondrocytes to 
respond to cytokines in this study. The effect of cartilage breakdown in rat models 
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of arthritis may also rely upon interaction with other moieties, such as synovium 
cells, that were not present within the in vitro culture system used in the current 
study (chapters 3, 4 and 5). Indeed, studies performed in chapter 7 showed that 
introduction of fibroblast cells into the culture system greatly enhanced release of 
GAGs following addition of cytokines to fibroblast-cartilage co-cultures 
(discussed in section 9 .1.4 ). 
Other studies have shown that aggrecanase activity may be indepedent of IL-l~ in 
bovine cartilage (IIic et a/. , 2000). However, aggrecanase activity in rat cartilage 
has not been confirmed to date. Lack of aggrecanase activity in rat cartilage may 
be another factor resulting in the lack of response to IL-l~ in the current study. 
Control conditions and IL-l~ treated cartilages used to produce results in chapter 
3 were compared with the responses generated by CSFs (chapter 4). 
9.1.1: The effects ofCSFs on rat cartilage explants. 
CSFs have been detected in the synovial joint and have been shown to be 
produced by cartilage chondrocytes (Campbell et a/., 1991 and 1993) and tissues 
surrounding the synovial joint (Hamilton et a/., 1993). However, the effects of 
CSFs on cartilage explants in an in vitro system have not been previously studied. 
The rat cartilage explant system was used to measure the effects of CSFs with 
respect to GAGs, NO and PGE2. 
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It was interesting to note that G-CSF reduced GAG concentrations detected in 
cartilage explants compared to controls, yet did not increase release of GAGS into 
the cutlure media. Like G-CSF, IL-6 has been described by van de Loo et a/., 
(1997) as a cytokine that reduces GAG concentrations in articular cartilage. 
Analysis of the structure of IL-6 has revealed that it has comprises a four domain 
alpha helical structure (Appendices II) (Somers et a/., 1997). Comparison with the 
structure of G-CSF has shown that it also has a similar structure (Zinc et al., 
1994), (Appendices III). 
It has been shown by (Taga and Kishimoto, 1997) that IL-6 binds to a gp 130 that 
is a common component in the IL-6 family of cytokine signalling pathway and that 
the G-CSF receptor has a high percentage homology was the gp 130 subunit of the 
IL-6 receptor complex. IL-6 binds to the IL-6 receptor complex which in turn 
activates the signal transducer and activator of transcription 3 (STAT3) factor. 
G-CSF, like IL-6, also activates the STAT 3 pathway in I. STAT 3 is translocated 
to the cell nucleus where it activates various transcription factors, including 
CCAIT enhancer binding protein (C/EBP) (Chen eta/., 1999). The CIEBP family 
of proteins have been associated with signal transduction pathways initiated by 
both IL-l and IL-6 and C/EBP proteins have been demonstrated to interact with 
nuclear factor-KB (NF-KB) proteins (Xia, 1997). It is therefore possible that 
G-CSF may influence GAG concentrations and nitrite production in cartilage 
explants via similar mechanism to those described with regard to IL-6 signaling. 
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Unlike G-CSF, GM-CSF and M-CSF did not influence the role of chondrocytes in 
rat cartilage explants with respect to GAG concentration, and nitrite and PGE2 
production. However, IL-3 induced a significant increase in production of PGE2 
by cartilage explants in the culture media. These findings suggest that both G-CSF 
and IL-3 influence rat cartilage chondrocytes within a cartilage matrix. It has been 
suggested that both PGE2 and NO may compromise GAG stability in the cartilage 
matrix directly, (Hassan eta/. , 1998; Prete et a/., 1997). Alternatively, CSFs may 
activate transcription factors such as C/EBP and NF-KB that may initiate 
transcription and production of other inflammatory mediators such as cytokines, 
metalloproteinases, reactive oxidative species and prostaglandins. Endogenous 
production of inflammatory mediators by cartilage explants may then increase the 
potential for cartilage breakdown. ln disease pathology associated with arthritic 
disease this effect may serve to increase migration of immune cells toward 
articular cartilage surfaces and increase their potential to produce further pro-
inflammatory cytokines, metalloproteinases, ROS and prostaglandins. This effect 
in turn may drive the destructive process and produce a self perpetuating circle of 
events that would promote loss of GAGs from the cartilage matrix. Loss of GAGs 
from the matrix would decrease the hydration of cartilage and its concordant 
abillity to maintain integrity under compressive forces resulting in loss of structure 
and consequential loss of function. 
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9.1.2: The combined effects of CSFs with IL-lf3 on rat cartilage explants. 
Studies by Campbell eta/. (1991; 1993) revealed that cartilage explants produce 
CSFs in response to IL-l f3. It is therefore possible that CSFs and IL-l f3 may be 
located in the proximity of articular cartilage in a combined presence during 
arthitic disease. Cartilage explant experiments in this study revealed that 
combined treatment with IL-l p and G-CSF caused increased loss of GAGs into 
the culture media. This compared to separate treatments with IL-l p (Fig 3.13) and 
G-CSF (section 4.12), where GAG concentrations in the media were unaffected. 
This showed that the combined effect of these cytokines had a greater potential to 
reduce GAG concentrations in explants compared to separate treatments. PGE2 
concentrations were also assessed following combined treatments with IL-l p and 
CSFs (chapter 5). 
PGE2 concentrations were increased by IL-3 and lL-1 P (Fig 5.27) in the combined 
study. This was not surprising since lL-1 P (Fig 3.16) and IL-3 (Fig. 4.27) 
promoted production of PGE2 as separate treatments. Unlike IL-3, GM-CSF did 
not cause cartilage explants to produce elevated concentrations of PGE2 in the 
culture media (section 4.19). However, PGE2 concentrations were increased in 
culture media when combined treatments of GM-CSF and IL-l p were 
administered to cartilage explants (Fig. 5.1.8). These experiments suggested that 
both IL-3 and GM-CSF had a synergistic effect with IL-l P with regard to PGE2 
release from rat cartilage explants. This was interesting since both IL-3 and 
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GM-CSF signal through an identical f3-chain in the receptor complex (Mulhern et 
al., 2000). These cytokines initially bind to a cytokine specific a-chain prior to 
recruitment of the common f3-chain in order to transduce signals within the cell. 
The f3-chain consists of an intracellular domain containing eight phosphorylatible 
tyrosine residues that are required for JAK-STAT signalling and an extracellular 
domain containing sequence features that are restricted to cytokine receptors. 
Both IL-3 and GM-CSF have been demonstrated to have an overlapping hierachy 
of function in hematopoietic cells, (Nimer and Uchida, 1995). It is therefore 
speculated that GM-CSF and IL-3 may contribute to PGE2 production in vivo 
since the there is evidence for GM-CSF receptor expression in both RA and OA 
synovial tissue (Berenbaum eta/., 1994). 
Experiments in the present study showed that [L-1 f3, TNF-a. (chapter 3) and CSFs 
interact with cartilage in an in vitro environment and induce release of NO and 
PGE2• In an in vivo environment these effects would be integrated by interactions 
with other cell types. The synovial joint membrane, which under normal 
physiology is relatively acellular, is infiltrated in RA pathology by T cells, 
macrophages and plasma cells (Odeh, 1997). In rheumatoid arthritis the hyper 
proliferation of the synovium results in an invasive pannus tissue composed of 
fibroblast-like cells growing toward the surface of articular cartilage within 
synovial joints (Edwards, 1995). In a further study the intention was to extend the 
cartilage explant model to incorporate a fibroblast cell type. Fibroblasts were 
chosen to culture with cartilage explants to determine if the effects of IL-l f3 and 
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CSFs would be enhanced or diminished by their presence. Swiss 3T3 fibroblasts 
were intially used in a pilot study to determine if they released GAGs, NO or 
PGE2 in response to culture with inflammatory cytokines (chapter 6). 
9.1.3: Fibroblast monolayers and their response to inflammatory cytokines. 
Swiss 3T3 fibroblasts were initially cultured in control media identical to that used 
in cartilage explant studies. This provided a basis for studying fibroblasts activity 
in conditions that could be repeated using a co-culture system in following 
experiments. Fibroblasts in control conditions produced a basal level of PGE2 in 
the absence of IL-1(3, however, NO and GAGs were not detected in the culture 
media. Swiss 3T3 fibroblasts have been shown to possess GAG like moieties on 
the surface of the cell membrane (Tsiganos et a/. 1982), however GAGs were not 
detected in media from any experiments involving fibroblast monolayers 
(chapter 6). 
Treatment with TNFa caused an increased production of NO (6.1.4) and PGE2 
(6.1 .5) by Swiss 3T3 fibroblasts. Treatment with IL-113 also caused an increased 
production of NO (Fig 6.1.2) and PGE2 (Fig 6.1.3) by Swiss 3T3 fibroblasts. This 
was anticipated since IL-l has been shown to induce PGE2 and NO production by 
Swiss 3T3 cells (Burch et a/., 1989). CSFs were also applied to fibroblasts in 
order to determine if they increased the production of the previously measured 
parameters, however, no changes in production of NO and PGE2 were observed 
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(section 6.1.6). Combined treatments with IL-l f3 and CSFs produced increased 
levels of NO and PGE2 compared to controls. The objectives were achieved since 
it was shown that Swiss 3T3 fibroblast did not release GAGs into the culture 
media and that Swiss 3T3 fibroblasts were responsive to IL-l f3 treatment. Swiss 
3T3 fibroblasts were then used in fibroblast-cartilage co-culture experiments 
(chapter 7). 
9.1.4 Cartilage-fibroblast culture as a model of cartilage breakdown. 
Integration of Swiss 3T3 fibroblasts and rat femoral head cartilages (chapter 7) 
produced results that were markedly different from previous experiments 
(chapters 3, 4 and 5) with regard to GAG release from cartilage explants. Addition 
of IL-l f3 to the system caused an increased release of GAGs (Fig 7.11) from the 
cartilage explants and elevated levels of nitrite (Fig 7.12) and PGE2 (Fig 7.13) in 
the culture media compared to control fibroblast-cartilage co-cultures. These 
results demonstrated that fibroblasts co-cultured with cartilage explants caused 
increased loss of GAGs from cartilage explants and that this process was 
increased in magnitude by IL-l f3. It was assumed that all GAGs detected in the 
media were derived from cartilage explants and not fibroblasts, since GAGs were 
not detected in either control or cytokine treated fibroblast media (chapter 6). In an 
in vivo scenario fibroblasts may influence breakdown of the cartilage matrix in 
normal physiology and in RA due to interactions with infiltrating cells (Odeh, 
1997) and synovial fibroblasts (Edwards, 1995). 
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A recent study showed that CSFs may also increase the processes leading to 
cartilage destruction in vivo. It was postulated that a local network of CSFs may 
exist that orchestrate the cellular interactions and resulting tissue damage in 
arthritic lesions (Campbell et a/., 2000). In a murine model of joint inflammation 
it was demonstrated that systemic exogenous IL-113, M-CSF and GM-CSF all 
increased synovitis, i.e. proliferation of the synovium, infiltration of inflammatory 
cells into blood vessels around the synovium. 
ln the present study the effects of CSFs were examined with regard to GAGs lost 
from cartilage and production of NO and PGE2 in the co-culture system. The 
objective of this study was to determine if exogenous CSFs had a direct effect on 
the level of GAGs released from cartilage explants in the presence of fibroblasts, 
as observed with IL-113. 
Treatment of co-cultures with IL-3 caused an increased Joss of GAGs from 
cartilage explants on days I and 4 (Fig 7.1.4). Conversely, addition of G-CSF, 
GM-CSF, M-CSF to fibroblast-cartilage co-cultures did not influence GAG loss 
from cartilage explants (Fig. 7.1.4). Individual treatments with CSFs did not 
increase nitrite concentrations (Fig. 7.1.5) in co-cultures. This was surprising since 
G-CSF increased nitrite production in cartilage explants (Fig 4.1.3). Levels of 
PGE2 were elevated by G-CSF, GM-CSF, IL-3 in the co-culture system, but not by 
M-CSF (Fig. 7.1.6). 
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Treatments with CSFs combined with IL-113 were also used in the co-culture 
system. The observed effects of combined treatment with CSFs and IL-113 
resembled those observed with IL-113. GAG concentrations in the media of 
combined treatment groups showed a trend of being elevated compared to controls 
(Fig 7.1.7), although no single combination treatment appeared to be elevated 
compared to other combination treatment groups or treatments with 
IL-113 (Fig 7.1.1 ). Nitrite (Fig 7.1.8) and PGE2 (Fig 7.1.9) levels were elevated in 
all combined treatment groups compared to controls. Elevated nitrite levels in all 
combined IL-113 and CSF treated groups (Fig 7 .1.8) compared to IL-113 induced 
nitrite concentrations (Fig. 7.1 .2) in co-cultures. Elevated PGE2 levels in all 
combined IL-113 and CSF treated groups (Fig 7.1 .9) compared to IL-113 induced 
PGE2 concentrations (Fig. 7.1.3) in co-cultures. These results suggest that CSFs 
combined with IL-113 did not affect GAG loss (Fig. 7.1.7), nitrite production (Fig. 
7.1.8) and PGE2 production (Fig. 7.1.9) in this in vitro fibroblast cartilage co-
culture model. However, the results of this study may support the evidence by 
Campbell et a/., (2000), suggesting that CSFs may increase the synovitis in a 
mouse model of joint inflammation. Indeed, if PGE2 production is increased in 
vivo, it may promote pro-inflamatory activity by increasing blood vascular 
permeabillity (Am in eta/., 1997), increase bone resorption (Horton eta/. , 1999). 
Similarly, ifNO production is increased in vivo, it may promote GAG degradation 
in the cartilage matrix (Hassan et a/., 1998), activation of MMPs (Murrel et al., 
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1994), induction of COX-2 activity (Honda eta/. , 2000) and increased synthesis 
ofPGE2 (Blanco and Lotz, 1995). 
It was apparent from this study, using co-cultured fibroblasts and cartilage 
explants, that G-CSF, GM-CSF and IL-3 increase the production of PGE2 
(Fig. 7.1.6). The concentrations of PGE2 produced in this study (>200ng/ml) 
suggested that PGE2 was derived from fibroblasts. Previous experiments (chapter 
6) showed that concentrations of PGE2 produced by fibroblasts were a magnitude 
higher than those produced by cartilage explants (chapters 3, 4, and 5). Treatments 
with CSFs on fibroblast monolayers did not increase PGE2 production (section 
6.1.7). It was speculated that CSFs in the co-culture system may have induced 
production of inflammatory mediators, such as IL-l p and I or TNFa, by rat 
cartilage explants. These inflammatory mediators may have then induced 
production of PGE2 by fibroblast monolayers in the co-culture system. This 
hypothesis was considered since GM-CSF increases synthesis of both IL-113 and 
TNFa in monocyte I macrophage cells (Deresinski and Kemper, 1998). 
It was demonstrated in the present study that IL-113 was required to produce 
increased GAG release from explant matrix and production of NO in the co-
culture system. The production of NO was considered with particular interest 
since it may have direct effect on the cartilage matrix. A study was performed 
separately on cartilage explants and fibroblasts to examine the effects of 
intracellular pathways leading to production of NO using specific inhibitors of 
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elements implicated in mediating lL-113 intracellular signalling. This involved 
using specific inhibitors to target p38 MAP kinase and ERK 1 I ERK 2 pathways 
(chapter 8). 
9.1.5: Use of specific inhibitors to block p38 MAP kinase and ERK 1 I ERK 2 
in fibroblasts and rat cartilage explants. 
The research project was concluded by performing a study to determine if p38 
MAP kinase and ERK IIERK 2 inhibition resulted in inhibition of nitrite 
production, induced by IL-113. p38 MAP kinase and ERK 112 target were selected 
and targeted using the specific inhibitors SB 203580 and PO 98059, respectively 
(Fig. 8.1.1 ). 
Results from experiments conducted on fibroblasts showed that both SB 203580 
and PO 98509 inhibited nitrite production induced by IL-113 . It was therefore not 
surprising to observe that combined treatments with these inhibitors also reduced 
IL-113 induced nitrite production in fibroblast monolayers. These results 
demonstrated that production of nitrite in fibroblasts requires the activity of both 
p38 MAP kinase and PO 98059. These were comparable with a study that showed 
p38 MAP kinase reduced iNOS production and release of nitrite in bovine 
chondrocyte monolayers (Badger et al., 1998). 
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A comparable study was performed on rat cartilage explants to determine if 
similar effects could be detected in chondrocytes within the cartilage matrix in an 
in vitro system. In contrast to experiments with fibroblast monolayers, SB 203580 
and PD 98059 failed to suppress the effect of IL-113 on production. However, IL-
113 induced nitrite production was decreased by combined treatment SB 203580 
and PD 98059. These results suggested that both p38 and ERK II ERK 2 are 
components in the IL-113 signalling pathway leading to increased generation of 
nitric oxide in rat chondrocytes within cartilage explants. It was speculated that 
the cartilage matrix impeded the effectiveness of these inhibitors to interact with 
the intracelular targets within chondrocytes. 
9.1.6: Summary 
The findings from this thesis produced several key conclusions about the use of 
the cartilage explant system coupled with fibroblasts as an in vitro model of 
cartilage response to cytokines. 
Firstly, cartilage is a tissue that is variable in its structure and responsiveness to 
stimuli depending upon the location and species from which it is derived. It is 
important to consider the heterogeneity of its structure and standardise the 
conditions and environment within an in vitro system. Secondly, cartilage is a 
tissue that interacts with its surrounding environment in vivo. Use of cartilage 
explants in vitro provides a useful indication of chondrocyte functions (chapters 3, 
4 and 5), however, these observed functions may be impeded and modified by 
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interactions with fibroblasts, as demonstrated by studies using the co-culture 
system (chapter 7). 
In this system, IL-113 has been characterised as a cytokine that increases markers 
of inflammation by cartilage explants (chapter 3). Although IL-113 did not cause 
GAG release in rat cartilage explants (chapter 3), the catabolic effects of IL-113 
were demonstrated in the co-culture system (chapter 7). The co-culture model has 
potential use as a system for screening activity of specific compounds that may be 
designed to reduce GAG loss from the cartilage matrix. There are also many other 
factors that may be studied in such a system, such as the synthesis of 
proteoglycans by chondrocytes, the production and secretion of MMPs, 
chemokines and the activity characterised anti-inflammatory cytokines such as IL-
l 0 and IL-13. It would also make an interesting study to examine the loss of 
collagenous components from the cartilage extracellular matrix. This would 
provide further evidence of catabolic activity occuring in the system. 
The effects of the CSFs on cartilage explants were also interesting and novel; the 
study revealed that CSFs may indeed increase the potential of fibroblasts and 
cartilage to regulate the inflammatory responses. Notably, G-CSF and IL-3 were 
shown to be involved in the regulation of NO and PGE2 production (chapter 4), 
respectively, and G-CSF, GM-CSF and IL-3 increased PGE2 production when 
combined with IL-113 and in the co-culture system (chapter 7). The Effects of 
G-CSF with IL-113 strongly suggest that there may be combined effects resulting 
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in loss of GAGs and increased production of nitrite by cartilage explants alone 
(chapter 5). These novel observations show that CSFs may play an important role 
in the pathology of joint disease and inflammation by increasing the production of 
pro-inflammatory mediators produced by IL-l~· 
The use of inhibitors to suppress NO production also generated novel data 
regarding p38 and ERK roles in the production of nitrite induced by 
IL-l~ (chapter 8) in rat cartilage explants. It was concluded that these specific 
inhibitor molecules may be useful tools to elucidate specific signal transduction 
pathways involved in inflammation associated with inflammatory joint pathology. 
It was the aim of this thesis to provide an insight into the nature of cartilage 
activity and cytokines within an in vitro system and that data from this study may 
provide an indication of the interactions between cartilage, fibroblasts and 
cytokines that may lead to cartilage breakdown in diseases such as rheumatoid 
arthritis. 
245 
Appendix I : Associated publications 
Stephan, S., Purcell W.M., Punchard, N, and Chander C.L. (1999). Effects of 
granulocyte macrophage colony stimulating factor and interleukin-3 on 
prostaglandin-E2 and nitric oxide production in articular cartilage. Mediators of 
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Chondrocytes. International Journal of Tissue Reactions- Experimental and 
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Appendix II : Structure of IL-6 
Image of IL-6 (Somers eta!. , 1997) constructed from PDB files using RasMol. 
(PDB identification no: 1 ALU) 
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Appendix III : Structure of G-CSF 
Image ofG-CSF (, Zinc eta/., 1994) constructed from PDB file using RasMol. 
(PDB identification no: 1 GNC) 
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Appendix IV: Internet Web Page Addresses 
Microanatomy Web Atlas (January 2001) 
http://cellbio.utmb.edu/microanatomy/bone/cartilage_and_bone_cells.htm#CHONDROCYTES 
American Academy of Orthopaedic Surgeons (January 2001) 
http:/ I orthoinfo.aaos.org/brochure/thr _ report.cfm ?Thread _I D=2&topcategory= Arthritis 
Appendix V: IC50 ofiL-lB 
IC5o produced from IL-l~ induced production of nitrite by rat cartilage 
explants during 3 days 
Nitrite (uM) 
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~ --------------------------------------------------. 
40 
35 
30 
!-+-nitrite I 
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lCso- I 0 ng/ml 
0 ~----------~----------~------------------------~ 
10 50 100 
IL- l concentration (ng/ml) 
Appendix V: Effect of IL-l~ on nitrite production by rat femoral head cartilages 
during 3 days in culture. Control concentrations of nitrite were deducted from 1-
1 OOng/ml treatments with IL-l~ . The IC5o was calculated to be ~ 10 ng/ml. 
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